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ABSTRACT 
 
Depression Detection in Hospitalized 
Cardiac Patients 
 
by 
 
Martine S. Geddes, Master of Science 
Utah State University, 2010 
 
Major Professor:  Phillip J. Waite, Ph.D. 
Department:  Health, Physical Education, and Recreation 
 
Depression has been shown to increase an individual’s risk for heart disease.  Despite this 
finding, physicians are not identifying depression in their hospitalized cardiac patients.  This 
study looked at hospitalized cardiac patients and determined whether their physicians were 
identifying depression in those that scored > 5 on the PHQ-9 depression inventory.  Methods 
included assessing patient depression during their stay at an intensive care unit using the PHQ-9.  
Those patients scoring > 5 were determined as depressed.  Chart audits were performed after the 
patient discharged from the hospital to discover whether physicians were identifying these 
patients as depressed.  The results showed that out of 111 surveys, 83 had a score of > 5, meaning 
that 74.7% of hospitalized cardiac patients have some type of depression while in the hospital, 
ranging from mild, moderate, or severe.  Of those 83 patients, only 9 or 10% were identified as 
depressed by their physician during their stay at the hospital.  Conclusions suggest that although 
depression appears to be prevalent in the hospitalized cardiac patient, physician detection of such 
is very low. 
(114 pages) 
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CHAPTER I 
 
INTRODUCTION 
 
Background of the Problem 
 
 Evidence suggests that depression promotes atherosclerosis in the cardiac patient 
(Glassman, 2007; Goldstein, 2006; Januzzi & Pasternak, 2002). Depression can increase chronic 
inflammation in the arteries, platelet abnormalities, and other side effects that can result from 
chronic stimulation of the sympathetic nervous system (Feinstein, Blumenfeld, Orlowski, 
Frishman, & Ovanessian, 2006). Depressive symptoms, whether formally diagnosed as clinical 
depression or not, can be strong independent predictors of mortality, worse health status, 
decreased medical compliance, recurrent cardiac events, and increased patient usage of health 
care services (Amin, Jones, Nugent, Rumsfeld, & Spertus, 2005). 
 Increased platelet aggregation/activation has been linked to depression (Feinstein et al., 
2006; Goldstein, 2006; Januzzi & Pasternak, 2002; Lane, Carroll, & Lip, 1999). Higher levels of 
platelet factor IV and beta thromboglobulin have been demonstrated in patients with depression 
and have been found to increase thrombus formation. Depression increases the levels of c-
reactive protein (CRP), which is a marker for an inflammatory process in the artery walls thought 
to be a predictor of coronary heart disease (CHD) (Feinstein et al., 2006; Goldstein, 2006; Januzzi 
& Pasternak, 2002). Research shows that depression can raise cortisol levels in the blood. High 
cortisol levels may increase endothelial inflammation by excess clotting. This has been found to 
be associated with hypertension, increased cholesterol, and glucose dysregulation (Januzzi & 
Pasternak, 2002; Kemp, Malhorta, Franco, Tesar, & Bronson, 2003).  
 Evidence shows that there may be certain risk factors that influence the development of 
depression for the cardiac patient. A positive family history of depression is the most prevalent 
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risk factor (Lesperance & Frasure-Smith, 2000). Although psychological stressors do not always 
indicate risk factors for depression, they can be a potential cause (Thornton, 2001).  There are 
certain clusters of risk factors for depression that are also well-known risk factors for CHD and 
include: smoking, disability or poor New York Heart Association Class (NYHA) stress and high 
workload, and history of CHD (Lehto et al., 2000). Social isolation and poor social support have 
been shown to increase an individual’s risk for developing depression (Kemp et al., 2003; 
Lesperance & Frasure-Smith, 2000; Thornton, 2001).   
 A newly emerging idea that is receiving a great deal of attention is called the type “D” 
personality. This personality type is considered a high-risk personality and is characterized by 
negative affectivity and social inhibition combined (Thornton, 2001). This personality type is 
rapidly replacing the highly regarded notion of the type “A” personality in regards to CHD. Each 
of these risk factors for depression will be discussed below.  
 The prevalence of depression among cardiac patients can range anywhere from 15-65% 
(Amin et al., 2005; Feinstein et al., 2006; Herrmann-Lingen, 2001; Kaptein, De Jonge, Van Den 
Brink, & Korf, 2006). Despite this knowledge, physicians, including cardiac physicians, are 
under-detecting this problem (Amin et al., 2005; Herrman-Lingen, 2001; Huffman et al., 2006; 
Januzzi & Pasternak, 2002). Evidence suggests that depression experienced after a myocardial 
infarction (MI) is not transient. At 3, 6, 9, and 12 months post-MI, research has found that 
patients may still meet criteria for moderate to severe depression (Frasure-Smith, 2000; Lane et 
al., 1999). 
 The effects of untreated depression can seriously complicate recovery and increases the 
risks of further cardiac morbidity or mortality (Carney, Freedland, Sheline, & Weiss, 1996; Kemp 
et al., 2003). The more severe the depression is, the greater the risk of death following a cardiac 
event (Kemp et al., 2003). Non-adherence to a physician’s medication treatment plan is 
increasingly recognized and can cause adverse cardiac outcomes (Ali, Gehi, Na, & Whooley, 
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2007). 
 The American College of Cardiology (ACC) and the American Heart Association (AHA) 
recommend routine assessments into depressive symptoms in the cardiac patient in order to 
establish appropriate interventions and follow up (Amin et al., 2005; Thornton, 2001). The use of 
a screening procedure can greatly improve the recognition of depression (Magruder-Habib, Zung, 
& Fuessner, 1990). Positive screening should receive a thorough diagnostic interview and a 
criteria-based diagnosis (Hermann-Lingen, 2001). The detection and treatment of depression 
should be a critical element in the overall rehabilitation of the cardiac patient (Lehto et al., 2000). 
 Prior research has been conducted to examine depression among the hospitalized MI and 
CHF patient (Amin et al., 2005; Huffman et al., 2006; Kaptein et al., 2006). Findings suggest that 
subjects with significant depressive symptoms during hospitalization that increased during the 
post-MI year had a significantly higher rate of new cardiovascular events, which was not 
explained by any initial measure of cardiac impairment (Kaptein et al., 2006). To date, however, 
more research is needed to investigate the prevalence of under-detection of depression among 
patients with other cardiac diagnoses requiring hospitalization. These diagnoses would include 
MI, CHF, atrial fibrillation, unstable angina, acute coronary syndrome (ACS), and rule out MI 
with a past history of cardiac problems.  
Problem Statement 
 Since the mid-1990s, evidence has suggested that depression can aggravate the course of 
multiple cardiovascular conditions (Glassman, 2007; Feinstein et al., 2006). Despite the evidence, 
depression detection in the hospitalized cardiac patient remains low (Amin et al., 2005; Hermann-
Lingen, 2001; Huffman et al., 2006; Januzzi & Pasternak, 2002). The present state of knowledge 
regarding depression detection in the cardiac patient for diagnoses other than MI and CHF is very 
limited. A better understanding of the rate of depression detection within other diagnoses is 
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needed in order to better address those patient’s needs.  
Purpose of the Study 
 This study was carried out in an attempt to expand the research that has already been 
conducted on hospitalized MI and CHF patients by assessing the rate of detection of depression 
among hospitalized patients diagnosed with a wide spectrum of cardiac related disorders.  
Research Questions 
The following research questions were addressed in this study: 
1. Are cardiologists and/or internal medicine physicians detecting depression in their 
cardiac patients during a hospital admission accurately as compared to the PHQ-9? 
2. Are there differences between the rates of depression in the different diagnostic 
groups? 
3. Are there differences between the rates of depression in male and female patients? 
4. Are there differences between the rates of depression in patients who are married, 
single, widowed, or divorced? 
5. Does the age of a patient predict the risk for depression following a cardiac event? 
6. Are there differences between the rates of depression in patients that had a prior 
cardiac history versus those with a new diagnosis? 
Limitations 
The limitations of the study are listed below: 
1. Some (n = 4) patients were transferred to a hospital that provides a higher level of 
care in a very short period of time, which made it impossible for those patients to participate in 
the study. 
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2. Due to the fast-paced nature of an intensive care unit, administering the chosen 
depression inventory was not feasible with some patients (21 individuals); i.e., those preparing for 
transfer (n = 4), patients with altered levels of consciousness (n = 5), the inability of the 
researcher to administer the PHQ-9 due to discharge of the patient (n = 9), and those that declined 
to fill out (n = 3). 
Delimitations 
 The delimitations of the study are listed below: 
1. The sample captured in this study is unique to this region and may not be 
generalizable to other populations of cardiac patients. 
2. All patients were 18 years of age or older.  
Operational Definition of Terms 
For the purpose of this study, the following terms and definitions were used. 
Coronary Heart Disease (CHD): Myocardial damage due to insufficient blood supply. 
The disease is caused by pathological changes in the coronary arteries sufficient to interfere with 
adequate blood flow (Davis, 1978). 
Coronary Artery Bypass Grafting (CABG): A technique that involves using the patient’s 
greater saphenous vein, as a bypass graft between the proximal aorta and the diseased coronary 
artery distal to an atherosclerotic lesion. The internal mammary or radial arteries can also be used 
(Ehrman, Gordon, Visich, & Kateyian, 2003). 
Congestive Heart Failure (CHF): A condition in which the heart is unable to pump 
enough blood to meet the needs of the body. This condition occurs because the heart becomes 
weakened by conditions or diseases that damage the heart muscle (Intermountain Health Care, 
2005). 
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Cortisol: An adrenal cortical hormone, usually referred to as hydrocortisone. It is 
important due to its regulatory action in metabolism of fats, carbohydrates, sodium, potassium, 
and proteins (Davis, 1978).  
Depression: According to the Patient Health Questionnaire (PHQ-9), a score of 1-4 
indicates minimal depression, 5-9 indicates mild depression, 10-14 indicates moderate 
depression, 15-19 indicates moderately severe depression, and 20-27 indicates severe depression 
(see Appendix A). 
Myocardial infarction (MI): A clinical condition caused by occlusion of a coronary artery 
or branches of the arteries that results in heart damage due to a part of the heart muscle being 
deprived of oxygen for a prolonged period of time (Ehrman et al., 2003). 
Platelets: Platelets play an important role in blood coagulation, hemostasis, and blood 
thrombus formation. When a small vessel is injured, platelets adhere to each other and the edges 
of the injury form a plug that covers the area. The plug, or blood clot formed soon retracts and 
stops the loss of blood (Davis, 1978).  
New cardiac diagnosis: The first time a patient has been diagnosed with anything that is 
cardiac related. 
Prior cardiac diagnosis: A cardiac diagnosis that is not the first cardiac diagnosis for a 
given patient. The patient has a prior history of cardiac problems.  
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CHAPTER II 
REVIEW OF THE LITERATURE 
 This chapter will review recent literature concerning the relationship between depression 
and heart disease and the detection of this problem by physicians. The literature review will 
examine the physiological relationship between depression and heart disease and will also 
include: (a) the prevalence of depression in the cardiac patient, (b) morbidity caused by 
depression, (c) mortality caused by depression, (d) risk factors that precipitate depression, and (e) 
the prevalence of physician detection. 
The Physiological Relationship Between  
Depression and Heart Disease 
 In the mid-1990s, evidence appeared to indicate that depression following an MI 
increased the risk of morbidity and mortality (Glassman, 2007). It was discovered that depression 
and pain share a common neurochemical pathway in that they are both influenced by serotonin 
and norepinephrine (Trivedi, 2004). Depression has become substantially more prevalent in 
patients with CHD than is widely recognized (Januzzi & Pasternak, 2002). This section will 
address the most widely accepted associations between depression and CHD. 
Increased Platelet Aggregation/ 
Activation and Depression 
 Increased platelet aggregation/activation has been linked to depression (Feinstein et al., 
2005; Goldstein, 2006; Januzzi & Pasternak, 2002; Lane et al., 1999). Higher levels of platelet 
factor IV and beta thromboglobulin have been demonstrated in patients with depression and can 
increase thrombus formation. Increased thrombus formulation can increase the risk of 
thromboembolic events (Goldstein, 2006; Lane et al., 1999). Serotonin has also been shown to 
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increase platelet cystosolic calcium which leads to exaggerated platelet response and enhanced 
platelet aggregation (Goldstein, 2006). 
 Serebruany et al. (2003) found that platelets play a key role in the progression of ACS. 
Clinical depression alone is also associated with platelet activation. This study set out to compare 
the concentrations of established biomarkers to reveal enhanced platelet activation in clinically 
depressed versus nondepressed patients. The subjects were enrolled in clinical trials for ACS. 
Two hundred and eighty-one baseline plasma samples were drawn from patients with acute MI (n 
= 41), ACS (n = 126), clinical depression and previous ACS within 6 months (n = 64), and from 
normal healthy controls (n = 50). The blood was drawn prior to application of any therapeutic 
strategies. Patients with ACS showed a greater degree of platelet activation than controls 
independently of the presence of depression. The depressed plus ACS group had higher plasma 
levels of all biomarkers compared with the nondepressed patients. The results reveal that clinical 
depression is associated with enhanced activation of platelets even above the level expected with 
ACS. 
 Musselman et al. (1996) conducted a study to investigate whether the depressed patient 
showed increased platelet reactivity. In vivo platelet activation was measured in 12 depressed 
patients and 8 normal, nondepressed control patients after overnight bed rest and also orthostatic 
challenge. The results showed that depressed patients demonstrated increased platelet activation 
at baseline as compared to the control patients. This increased susceptibility to platelet activation 
could be a mechanism linking depression as a significant risk factor for ischemic heart and 
cerebrovascular disease and/or mortality after MI.  
 Lederbogen et al. (2001) conducted a study that looked at platelet aggregability in 
patients with major depression both prior to and after 5 weeks of antidepressant therapy as well as 
in healthy control subjects. The participants consisted of depressed patients (n = 22) and healthy 
control subjects (n = 24). In this study, washed and rediluted platelets were stimulated. 
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Depression was associated with a higher aggregability after stimulation. Following 5 weeks of 
antidepressant therapy, aggregability was somewhat less exaggerated, but the effect unfortunately 
did not reach statistical significance.  
 Although contrasting information is available, the research tends to sway in the direction 
of increased platelet aggregability when depression is present (Lederbogen et al., 2001; 
Musselman et al., 1996; Serebruany et al., 2003). Even without achieving statistical significance 
in one study, it was still demonstrated that platelet aggregation had decreased following 
antidepressant therapy (Lederbogen et al., 2000). 
C-Reactive Protein (CRP) 
 Depression increases the levels of CRP, which is a marker for an inflammatory process in 
the artery walls thought to be a predictor of CHD (Feinstein et al., 2005; Goldstein, 2006; Januzzi 
& Pasternak, 2002). The National Health & Nutrition Examination Survey (NHANES III Study) 
was conducted utilizing a representative sample of the population from 1988 to 1994 with a total 
of 6,149 participants ranging in age from 17-39 years. These participants were initially free of 
any cardiovascular diseases or chronic inflammatory conditions.  The main predictor variable of 
interest was lifetime history of a major depressive episode assessed by the Diagnostic Interview 
Schedule. The main outcome variable was the presence or absence of an elevated CRP level (>22 
mg/dl). The results showed that men with a history of depression were 2.77 times more likely to 
have elevated CRP levels than were those with no history of depression (95% confidence interval, 
1.43-5.26). Furthermore, a history of major depressive disorder (MDD) was associated with 
elevated CRP, particularly for recent episodes, up to 6 months prior to the assessment. In women, 
a comparable association was weak and not significant (Danner, Kasi, Abramson, & Vaccarino, 
2003).  
 Suarez (2004) examined the relationship between anger, hostility, and severity of 
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depressive symptoms, alone and in combination, and CRP levels in healthy men and women. The 
sample included 127 multiethnic, healthy, nonsmoking men and women. Fasting blood samples 
were collected the same day that assessments of anger and hostility (Buss-Perry Aggression 
Inventory-BPAQ) and depression (Beck Depression Inventory- BDI) were performed. A 
Psychological Risk Factor (PRF) score was generated as a composite summary indicator of 
BPAQ and BDI. This study confirmed associations in multivariate analyses that were statistically 
adjusted for various factors known to increase CRP such as gender, age, body mass index (BMI), 
alcohol use, exercise, and lipids. In analysis adjusting for these confounders, CRP was positively 
and significantly associated with a composite summary indicator of anger, hostility, and severity 
of depressive symptoms. 
 Ladwig, Marten-Mittag, Lowel, Doring, and Koenig (2005) assessed the possible 
combined effects of depressive mood (DM) and CRP as it may predict a future fatal or nonfatal 
coronary event. CRP and DM were analyzed in 3,021 apparently healthy male subjects aged 45-
74. During a mean follow-up period extending 7.7 years, 165 CHD events occurred. CHD risks 
were estimated from Cox proportional hazard models and adjusted for age and survey and 
multiple risk factors. The age and survey adjusted interaction term of continuous CRP by DM 
showed a significant effect (HR 1.55; 95% CI 1.00-1.06; p = .037). A stratified analysis of 
subpopulations with (n = 986) and without (n = 2,035) DM showed that high CRP (> 3mg/L) was 
predictive in the group with DM (HR 2.69; 95% CI 1.32-5.47) but was not significant in the low-
level depression group (HR 1.55; 95% CI 0.89-2.69). Interestingly, the low CRP/no depression 
subgroup (n = 565) did not significantly predict a future CHD event. However, combined CRP 
and DM (n = 282) significantly predicted future CHD events (HR 2.91; 95% CI 1.25-2.18; p = > 
.0001). These results indicate that in apparently healthy men, a DM substantially increases the 
power of elevated CRP to predict subsequent cardiac event.  
 Dressler, Balieiro, Ribiero, and Dos Santos (2006) conducted a study on a Brazilian 
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population where there was a wide range of variation in both background characteristics (such as 
SES) and coronary artery disease risk factors. Fasting blood samples were obtained and evaluated 
for CRP in a sub sample (n = 258) of individuals. A sample of 271 individuals was also 
interviewed using the Center for Epidemiological Studies Depression scale. The mean + SD CRP 
for the entire sample was 0.43 + 0.44 mg/L, with 0.42 + 0.48 mg/L for men and 0.43 + 0.42 mg/L 
for women. Data were analyzed using multiple regression analysis, controlling for age, sex, BMI, 
SES, tobacco use, and both total and LDL cholesterol. Higher reported depressive symptoms 
were correlated with higher CRP for men (partial r = -.298, p = .004) and with lower CRP for 
women (partial r = -.154, p = .059). According to the authors, this difference in men and women 
could be the result of differential effects of sex hormones on stress reactivity and immune 
response. Conversely, this difference in the associations could be related to gender differences in 
the disclosure of emotion and the effects that self-disclosure might have on physical health and 
immune response. 
 Ford and Erlinger (2004) estimated the odds ratio (OR) of elevated CRP level (> 0.21 
mg/ml) associated with depression in 6,914 non-institutionalized men and women ages 18-39 
from the Third National Health and Nutrition Examination Survey (NHANES III). They found 
that the prevalence of lifetime major depression was 5.7% for men and 11.7% for women. A 
history of major depression was associated with elevated CRP level (OR, 1.64; 95% CI, 1.20 - 
2.24). The association between depression and CRP was stronger among men than among 
women. The results were adjusted for age, African American race, BMI, log triglycerides, 
diabetes, systolic blood pressure, smoking status, alcohol use, estrogen use in women, aspirin use, 
ibuprofen use, and self-reported health status. Compared with men that did not have a history of 
depression, CRP levels were higher among men who had a more recent (within one year) episode 
of depression (adjusted OR, 3.00; 95% CI, 1.39 -6.48) and who had recurrent (> 2 episodes) 
depression (adjusted OR, 3.55; 95% CI, 1.55 - 8.14). 
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 Douglas, Taylor, and O’Malley (2004) found conflicting results in a cross-sectional study 
of a cohort of 696, consenting, active duty US Army personnel undergoing a yearly physical. 
Depression was measured using the Patient Health Questionnaire (PHQ-9) and the Primary Care 
Evaluation of Mental Disorders (Prime-MD). A highly sensitive assay was used to measure CRP. 
The mean age of the group was 44 years (SD + 3; 82% male). The mean CRP level was 1.7 mg/L 
(range, 0.3 - 9.9; SD + 1.6 mg/L). Depression scores ranged from 0-26 with a mean of 2 (SD + 3). 
Depression scores correlated positively with CRP levels (r = .0085; p = .028), as did other 
variables known to be associated with CRP like BMI (r = .36), insulin levels (r = .22), mean 
arterial pressure (r = .21), triglycerides (r = .18), exercise (r = -.12), female sex (r = .097), current 
smoking status (r = .08), and high-density lipoprotein (r = -.09). Interestingly, after controlling 
only for BMI, the relationship between depression and CRP lost statistical significance among 
women (adjusted r = .08; p = .37), among men (adjusted r = -.11; p = .8), and overall (adjusted r 
= .047; p = .219). Depressive symptoms seemed to only weakly correlate with CRP. The 
relationship between depression and coronary artery disease is unlikely to be explained through 
direct effects on CRP levels, but may be mediated by BMI. According to the authors, the results 
could possibly be explained due to the fact that the study was performed on a relatively young, 
physically fit group that may not be representative of the general population. 
 The research seems to indicate that depression has an exponential affect on CRP levels 
and particularly when the depressive episodes have occurred within a year prior to CRP levels 
being drawn (Douglas et al., 2004; Dressler et al., 2006; Ford & Erlinger, 2004; Ladwig et al., 
2005; Suarez, 2004). Interestingly, in many studies, depression and elevated CRP were only 
associated with men and not women. Although there was an increase in CRP levels in women 
with depression, the difference was unable to achieve statistical significance (Douglas et al., 
2004; Dressler et al., 2006; Ford & Erlinger, 2004; Saurez, 2004). 
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Cortisol Levels 
 Research shows that depression can raise cortisol levels in the blood. High cortisol levels 
will increase endothelial inflammation by excess clotting. This can be associated with 
hypertension, increased cholesterol, and glucose dysregulation (Januzzi & Pasternak, 2002; Kemp 
et al., 2003).  
 Otte et al. (2004) tested cortisol levels in depressed CHD patients. Of 693 participants, 
138 (20%) had depression at the time of the study (42 + 25 vs. 36 + 20 µg/day, p < .01). The odds 
of having depression increased twofold for participants with the highest levels of cortisol 
compared to those with the lowest levels of cortisol. This association remained strong even after 
adjusting for certain confounding variables (OR 2.4, 95% CI 1.3 - 4.4, p = < .01). 
 Asnis et al. (1981) conducted a study on 25 unmediated hospitalized patients aged 26-64. 
These patients have severe MDDs and were evaluated clinically and endocrinologically by 
sampling plasma cortisol every 30 minutes for 24 hours. Measures of cortisol secretion did not 
correlate with symptom severity, but a relationship appeared between cortisol secretion and age 
during endogenous depressive illness. Following clinical recovery, as plasma cortisol levels 
moved back toward normal levels, there was no significant relationship between cortisol secretion 
and age. During depressive illness then, advanced age appeared to be an important factor as far as 
increasing cortisol levels but was of little significance as clinical recovery was achieved.  
 Preussner, Hellhammer, Preussner, and Lupien (2003), discovered that higher levels of 
depressive symptomatology were associated with greater cortisol levels after awakening. Forty 
healthy young men were assessed for severity of depressive symptoms using the Hamilton 
Depression Inventory and chronic and acute stress perception. The subjects were tested once a 
week, for 4 consecutive weeks, and provided saliva samples at 0, 30, and 60 minutes after 
awakening. The positive relationship between higher levels of depressive symptomatology and 
greater levels of cortisol seemed to be stronger in patients that were in the non-clinical range of 
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depression. Furthermore, depressive symptomatology and cortisol levels were significantly 
positively correlated with measures of chronic and acute stress perception.  
 Interestingly, Bhagwagar, Hafizi, and Cohen (2003) measured whether cortisol levels 
were elevated in fully recovered depressed patients. Thirty-one medication-free, recovered 
depressed patients and 31 matched healthy comparison subjects had salivary cortisol measured 
upon waking and at 15-minute intervals for the next hour. Their findings confirmed that greater 
secretion of cortisol may be present in depressed subjects even after clinical recovery and 
discontinuation of medication. This puts these patients at greater risk for recurrent episodes of 
depression as well as comorbid medical conditions such a coronary artery disease. 
 Although much research supports the idea that depressive symptomatology increases the 
level of cortisol in the bloodstream, there are some interesting differences discovered by various 
authors. Asnis et al. (1981) found a difference in raised cortisol levels based on advancing age, 
even though as the depression subsided, age was no longer a factor. Pruessner et al. (2003) found 
a positive relationship between depressive symptoms and increased cortisol levels, but the highest 
levels of cortisol were discovered in patients that were in the non-clinical range of depression. 
Bhagwagar et al. (2003) found that even after patients had clinically recovered from depression, 
their cortisol levels continued to be increased. It would appear that depression definitely raises 
cortisol levels and that increased cortisol levels cause inflammation in artery walls adding to an 
increased risk for coronary artery disease.  
Risk Factors for Depression 
Research shows that there may be certain factors that influence the development of 
depression for the cardiac patient (Kemp et al., 2003; Lehto et al., 2000; Lesperance & Frasure-
Smith, 2000; Thornton, 2001). A positive family history of depression is the most prevalent risk 
factor found in the literature (Lesperance & Frasure-Smith, 2000). Although psychological 
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stressors do not always indicate risk factors for depression, they can be a potential cause 
(Thornton, 2001). There are certain clusters of risk factors for depression that are also well-
known risk factors for CHD and include: smoking, disability or poor (NYHA) class, stress and 
high workload, and history of CHD (Lehto et al., 2000). Social isolation and poor social support 
have been shown to increase an individual’s risk for developing depression (Kemp et al., 2003; 
Lesperance & Frasure-Smith, 2000; Thornton, 2001). A newly emerging idea that is receiving a 
great deal of attention is called the type “D” personality. This personality type is considered a 
high-risk personality and is characterized by negative affectivity and social inhibition combined 
(Thornton, 2001). This personality type is rapidly replacing the highly regarded notion of the type 
“A” personality in regards to CHD. Each of these risk factors for depression will be discussed 
below. 
Positive Family History of Depression 
 Research has suggested that a positive family history of depression may have some 
impact on whether an individual will develop depression in his/her lifetime. In addition, family 
history of depression may give some important information about age of onset of depression. Due 
to its importance, a question regarding family history of depression is routinely asked by 
clinicians in a psychological exam (Nierenberg et al., 2007). This section will review the research 
conducted regarding the relationship between a positive family history of depression and its 
effects upon the development of depression. 
 Williamson, Birmaher, Axelson, Ryan, and Dahl (2004) conducted a study to examine 
the development of first-onset of MDD in children either coming from high familial risk of 
depression or low familial risk of depression. Those children that were free of any psychiatric 
disorder, that had at least one first degree and one second degree relative with a lifetime history of 
childhood-onset, bipolar, recurrent, or psychotic depression were included in the high risk group 
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(n = 76). Those children that were free of any lifetime psychiatric disorders and had no first 
degree and less than 20% of second degree relatives with a lifetime affective disorder were 
included in the low risk group (n = 63). Using the Schedule for Affective Disorders and 
Schizophrenia for School Age Children-Epidimiologic version (K-SADS-E), children and their 
parents were assessed. Follow-up interviews were conducted, on average, 18 months apart and 
extended for 6 years. The results showed that high-risk children had an approximate threefold 
increased risk of developing a first onset MDD compared with their low-risk counterparts (OR = 
3.21). The average age of new-onset MDD was 14.0 +/- 2.9 years with a range of 9.5 – 19.5 
years. High familial loading for affective disorders, a mother with depression or anxiety disorder, 
and a behavioral disorder in the child significantly contributed to the risk for developing 
depression in the future. 
 Furthermore, Tozzi et al. (2008) conducted a study to determine if the presence of family 
history of depression or anxiety, in a first-degree relative, caused a younger age of onset for 
depression. A sample of 1,022 cases with recurrent MDD was recruited from the Max Planck 
Institute and two affiliated hospitals. The Schedules for Clinical Assessment in Neuropsychiatry 
and questionnaires included demographic information, medical history, alcohol and tobacco use, 
personality traits, and life events. Survival analysis and the Cox proportional hazard model were 
used to determine if a family history of depression could indicate an earlier age of onset of 
depression. The results showed that of those patients that reported a positive family history of 
depression, there was a significantly earlier age of onset of depression than in patients that did not 
report a family history of depression (log-rank = 48, df = 1, p < .0001). The magnitude of the 
association between family history and depression varies according to age of onset, with the 
largest estimate for MDD onset prior to the age of 20 years (hazard ratio = 2.2, p = .0009), 
whereas family history is not associated with MDD when the onset occurs after the age of 50 
years (hazard ratio = .89, p = .5). Interestingly, feelings of guilt and anxiety, as well as functional 
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impairment due to depression, appear to characterize those individuals with a positive family 
history of depression. Therefore, a family history of depression appears to contribute to an earlier 
age of onset of depression, and may also affect the clinical features of the disorder. 
 Nierenberg et al. (2007) set out to discover if patients who have MDD and a positive 
family history are different from those patients that have MDD but no family history of 
depression. Demographic and clinical features were compared from a large cohort of patients 
seeking outpatient treatment with non-psychotic MDD who had reported that they had or did not 
have at least one first-degree relative who had MDD or bipolar disorder. All subjects (n = 4,005) 
were recruited from the STAR (*) D multi-center trial. The differences in demographics and 
clinical features for the patients with and without a family history of mood disorders were 
assessed after correcting for sex, age, race, and ethnicity. Of those patients that had a positive 
family history of mood disorder (n = 2,265; 56.5%), they were more frequently women and 
typically had an earlier age of onset of depression as opposed to those patients that had no family 
history of mood disorder (n = 1,740, 43.5%). No meaningful differences were found in depressive 
symptoms, recurrence, severity, daily function, and depressive subtype.  
 Mondimore et al. (2006) conducted a study to determine if a chronic course of depression 
could define a familial clinical subtype in MDD. A measure of lifetime chronicity of depressive 
symptoms such as recurrent mood symptoms most or all of the time, was tested in 638 pedigrees 
for familial aggregation, using the Genetics of Recurrent Early-Onset Depression (GenRED) 
project. The findings showed that in subjects with chronic depression, the mean age at depressive 
illness was lower, and that the rates of attempted suicide, panic disorder, and substance abuse 
were higher in those subjects with non-chronic depression. Interestingly, chronicity was assessed 
in 37.8% of affected first-degree relatives of subjects with chronic depression, and in 20.2% of 
relatives of subjects that had non-chronic depression. Analysis that used the generalized 
estimating equation model showed (OR = 2.52; SE = .39, z = 6.02, p < .0001) for the likelihood 
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of chronicity in a subject predicting chronicity in an affected relative. The findings suggest that 
the chronicity of depressive symptoms is familial, especially in preadolescent onset illness. 
 Puig-Antich et al. (1989) assessed first-degree (n = 195) and second-degree (n = 785) 
adult relatives of pre-pubertal children with major depression (n = 48). Participants were assessed 
by using the Family History-Research Diagnostic Criteria method (FH-RDC). Compared to 
normal control children, pre-pubertal children with MDD had significantly higher familial rates 
of psychiatric disorders in both first and second-degree relatives, especially MDD, alcoholism, 
and “other” diagnoses (mostly anxiety). Likewise, relatives of children in the non-affective 
psychiatric control (PC) group had lower rates of alcoholism, but higher rates of other (anxiety) 
disorder diagnoses, and intermediate rates of MDD. The research suggests that pre-pubertal onset 
of MDD may be especially likely in families with a high incidence of affective disorders when 
these particular families also have a high rate of alcoholism, and that a proportion of children 
without affective disorder but with separation anxiety were at high risk for the development of 
affective illness in their later years of life. 
 Klein, Lewinsohn, Seeley, and Rohde (2001) felt that family studies were a useful way to 
explore continuities and discontinuities between MDD amongst children and adolescents and 
MDD in adults. They conducted a family study of MDD in a large community sample of 
adolescents. The study included 268 adolescents with a history of MDD, 110 adolescents with a 
history of non-mood disorders, but no history of MDD through the age of 18 years, and 291 
adolescents with no history of psychopathology through 18 years. Psychopathology was then 
assessed in 2,202 first-degree relatives of all the subjects. This was assessed through semi-
structured direct and indirect family history interviews. The best estimate diagnoses were 
calculated by using all available data. The findings showed that the relatives of adolescents with 
MDD showed significantly elevated rates of MDD (hazard ratio [HR], 1.77; 95% CI, 1.46-2.31), 
dysthymia (HR, 1.79; 95% CI, 1.11-2.87), and alcohol abuse or dependence (HR, 1.29; 95% CI, 
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1.05-1.53). The results provide support that familial aggregation of depressive symptoms 
increases adolescent MDD. 
 A familial history of depression appears to be a strong predictor of depressive symptoms, 
especially when the history appears in first and second-degree relatives. It is very difficult to find 
any research to dispute the link between familial history and depression to some degree. Even 
more evident is the fact that a family history of depression affects the age at onset. The greater the 
family history, the earlier the onset of symptoms seems to appear (Klein et al., 2001; Mondimore 
et al., 2006; Puig-Antich et al., 1989; Tozzi et al., 2008; Williamson et al., 2004). 
Psychological/Life Stressors 
 There appears to be a causal relationship between stressful life events and major 
depression. This relationship may also be influenced by genetic factors that predispose to specific 
reactions to psychological and life stresses (Kendler, Karkowski, & Prescott, 1999). 
 Kendler et al. (1999) assessed the occurrence of 15 classes of stressful life events and the 
onset of DSM-III-R major depression over a one-year period in female twins extrapolated from a 
population-based registry. The sample included 24,648 person-months and 316 onsets of major 
depression. The stressful life events were rated individually on contextual threat and dependence 
(the degree to which the stressful life event could have resulted from the respondents behavior). 
The nature of the relationship between major depression and stressful life events was tested by 
discrete-time survival analysis that examined the relationship between dependence and the 
depressive effect of stressful life events and a co-twin control analysis. The results showed that 
while independent stressful life events were significantly associated with individual onsets of 
depression, if the level of threat was controlled, the association was significantly stronger for 
dependent events. The odds ratio (OR) for the onset of major depression during a month of a 
stressful event was 5.64 in all subjects, 4.52 within dizygotic pairs, and 3.58 within monozygotic 
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pairs. Stressful life events appear to have a substantial causal relationship with the onset of 
episodes of depression. Interestingly, about one-third of the association between stressful events 
and onsets of depression is non-causal, since individuals predisposed to major depression often 
select themselves into high-risk environments. 
 Marinic, Ozvacic, Katic, Polasek, and Lazic (2007) conducted a study on post-Croatia 
War (1991-1995) survivors in a town called Otocac, as this town was deeply affected by the 
effects of the war. The study was conducted ten years after the war. The goal of the study was to 
evaluate the prevalence of depression in general practice patients ten years following a major life-
altering stressful event, such as war. In 2005, 300 patients were picked randomly and 
systematically selected from a patient listing of a general practitioner in Otocac, Croatia. All 
subjects were 18 years or older. Using the ICD-10 classification of Mental and Behavioral 
Disorders, the patients were classified as having mild, moderate, or severe depressive episode 
with psychotic elements. The differences in the characteristics of depressed and non-depressed 
patients were tested using the chi2-test and Fisher’s test. The results showed that a total of 147 
(49%) of patients (65 male and 82 female) met the ICD-10 criteria for depressive episode. The 
distribution of severity of depression showed that the majority of depressed patients met the 
criteria for moderate (38.8%) and severe (39.5%) depression.  
 Chen et al. (2007) conducted a study to examine quality of life (QOL), prevalence of 
posttraumatic stress disorder (PTSD), and depression in firefighters in Kaohsiung, Taiwan. These 
firefighters experience an enormous amount of emotional shock from disasters, which could 
result in psychiatric impairments. This study involved a two-stage survey. In the first stage, 410 
firefighters were given the 36-item Short-Form Health Survey (SF-36) and the Disaster-Related 
Psychological Screening Test (DRPST) to assess QOL, possible PTSD, possible major 
depression, and related risk factors. In the second phase, psychiatrists categorized the cases based 
on the self-report questionnaires that were completed and separated, according to DSM-IV into 
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PTSD or major depression group, subclinical group, and health group. The results showed that 
prevalence rates for major depression and PTSD were 5.4% (22/410) and 10.5% (43/410), 
respectively. 
 Coruuble (2006) conducted a study to examine the relationship between the number of 
prior episodes of depression and the stressful life event exposure that triggered the current 
depressive episode. There were interesting relationships that were discovered such as: the linear 
increase of the number of depressive episodes with increasing age, severity of depression, female 
gender, and family history of depression. The most important relationship discovered, however, 
was that as the number of previous depressive episodes increased, the number of stressful life 
event exposures decreased, triggering a depressive episode. As the number of previous depressive 
episodes increased, it was discovered that even minor stressful life events could trigger a new 
depressive episode. 
 Amital (2008) further hypothesized that of those patients that suffer from treatment 
resistant depression (TRD), negative/stressful life events could be an independent risk factor for 
TRD. Subjects consisted of 107 unipolar MDD patients. These patients had all been treated for at 
least 4 weeks. The patients were assessed on their psychiatric and medical history and a total of 
seven categories of stressful life events. The results showed that 39.3% of the subjects were 
defined as TRD patients and 60.7% as non-TRD patients. TRD patients had more severe 
depression, greater suicidal attempts, longer episodes of depression, more hospitalizations, more 
benzodiazepine usage, and more antipsychotic usage. Job stress and financial stress were more 
prevalent in the TRD group.  
 The research seems to show that stressful events play a role in the precipitation of 
depression. It is also possible that depression might evolve as a process of several neuronal 
changes that occur in several brain regions. It is likely that these stressors could elicit 
neurochemical changes, possibly due to genetic determinants, and a wide array of environmental 
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and experiential factors (Anisman, Merali, & Stead, 2008).  
 Elovaino et al. (2007) studied the role of DRD2 polymorphism (rs1800497) in the 
association between depressive symptoms and stressful life events. Stressful life events are often 
associated with negative health outcomes, but it is apparent that there are large individual 
differences when it comes to coping with these events. Variants in dopamine receptor genes, such 
as DRD2, are associated with depression, but it is not clear if these variants can also modify the 
association between life events and depression. Prospective data were analyzed on life events and 
depressive symptoms in 1992 and 2001 that related to 1,611 young adults (672 men and 939 
women, aged 15-30). These subjects participated in the ongoing population-based cardiovascular 
risk in young Finns study. The results showed that depressive symptoms did increase as the 
number of stressful life events increased. However, the association was seen only in those 
subjects that carried A2/A2 (n = 872) genotype. The association was not detected in subjects that 
carried the A1/A1 of A1/A2 (n = 486) genotype. It seems that DRD2 polymorphism can 
moderate the effect of stressful life events on depressive symptoms. Furthermore, those 
individuals that carry the A2/A2 DRD2 genotypes may be more vulnerable to depression than 
others may.  
 Cervilla et al. (2007) conducted a study to test the potential gene-by-environment 
interaction between 5HTTLPR genotype at the serotonin transporter gene along with previous 
exposure to threatening life events (TLE) in regards to depression. There were a total of 737 
participants that were genotyped. Information was gathered regarding exposure to TLEs over the 
last six months, sociodemographic information, and family history of psychological problems 
among first-degree relatives. Trained interviewers used The Composite International Diagnostic 
Interview (ICD) to diagnose depression. Two outcomes were used:  the ICD-10 depressive 
episode, and ICD-10 severe depressive episode. Both the s/s genotype and the exposure to 
increased numbers of TLE’s were significantly associated with depression. Furthermore, the 
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5HTTLPR s/s genotype significantly modified the risk associated with TLE’s for both depressive 
outcomes. The s/s homozygous participants only needed minimal exposure to TLE (1) to increase 
their risk for depression. The same risk was only found in l/s or l/l individuals after a higher 
exposure to TLEs (2 or more). 
 Diener, Kuehner, Brusniak, Struve, and Flor (2008) studied the effects of 
uncontrollability and helplessness in the face of stressful life events as an important determining 
factor in regards to developing and maintaining depression. It has been suggested that the 
inability to deal with stressful life events could be related to dysfunctional prefrontal lobe 
functioning in the brain. Cognitive, behavioral, and physiological effects of stressor 
uncontrollability in depressed and healthy individuals were assessed. Relationships between 
altered cortical processing and cognitive vulnerability were also assessed. Twenty six 
unmedicated depressed patients and 24 matched healthy controls were tested in an expanded 
forewarned reaction (S1-S2) paradigm. Using a factorial design, stressor controllability varied 
across three conditions: (a) control, (b) loss of control, (c) restitution of control. Error rates, 
ratings of controllability, arousal, emotional valence, and helplessness were assessed throughout 
the experiment with the post-imperative negative variation (PINV) of the electroencephalogram. 
The results showed that depressed patients showed an enhanced frontal PINV during both loss of 
control and restitution of control. These patients also felt more helpless than the controls. The 
findings seem to indicate that depressed patients are more susceptible to stressor uncontrollability 
than their healthy control counterparts. The alterations in prefrontal functioning appear to add to 
this vulnerability and, therefore, can be linked to trait markers for depression. 
 The research found a wide variety of studies that seemed to find many explanations to the 
relationship between psychological/life stressors and depression. Kendler et al. (1999) found that 
independent stressful life events were significantly associated with individual onsets of 
depression, but that if the level of threat could be controlled, the association was significantly 
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stronger for dependent events. Corruble (2006) discovered that as the number of previous 
depressive episodes increased for an individual, the number of stressful events needed to trigger a 
depressive episode decreased. For those with TRD, negative/stressful life events could even be 
considered an independent risk factor for TRD (Amital et al., 2008). Furthermore, research has 
delved into the concept that life stressors could elicit neuro-chemical changes, possibly due to 
genetic determinants such as DRD2 polymorphism (Anisman et al., 2008; Elovaino et al., 2007). 
Cervilla et al. (2007) studied the gene-by-environment interaction as well. Uncontrollability and 
helplessness in the face of stressful events seems to make individuals more susceptible to 
depression (Diener et al., 2008). Although these ideas seem to be diverse, the general consensus 
seems to be pointing in the direction that stressful life events do increase an individual’s risk for 
developing depression. 
Smoking 
 There are several hypotheses associating smoking status as a risk factor for depression. 
First, according to the self-medication hypothesis, those who suffer from depressive symptoms 
use smoking to alleviate depressive symptoms. The second assumption asserts that chronic 
smoking may play a role in the etiology of depression. The third assumption suggests that there is 
a reciprocal mechanism between smoking and depression. The last assumption asserts that there 
are shared underlying genetic factors explaining this comorbidity (Lyons et al., 2008) 
 Almeida and Pfaff (2005) investigated the association between smoking and depression 
in people aged 60 years and older. A cross-sectional survey was administered to a sample of 
general practitioners patients in Western Australia. One thousand and thirty patients completed 
the survey and were divided into four groups according to smoking status: never smoked, ex-light 
smoker, ex-heavy smoker (> 20 cigarettes/day), and current smoker. Depressive symptoms were 
then assessed with the Center for Epidemiologic Studies-Depression Scale (CES-D). A CES-D 
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score of 22 or more was used to define the presence of clinically significant depression. The 
participants ranged in age from 60-101 years and 57.2% of participants were female. The mean 
CES-D score for never smokers was 10.5 + 8.3, for ex-heavy smokers it was 12.5 + 10.2, and for 
current smokers it was 13.1 + 11.0 , (p = .037). Current or past heavy smoking was associated 
with increased risk of clinically significant depression when compared to never or past light 
smoking (OR = 1.58, 95% CI, 1.01-2.48) after adjusting for age, gender, place of birth, social 
isolation, self-perceived health, and harmful or hazardous drinking. Past heavy smoking and 
current smoking were associated with increased frequency and severity of depression. 
 Lyons et al. (2008) conducted a study to examine the relationship between lifetime major 
depression, smoking, and nicotine dependence. There were 8,169 male twin subjects from the 
Vietnam War era. Twin registry biometrical modeling demonstrated a genetic influence on 
nicotine dependence, daily smoking, and major depression, and a family environmental influence 
on daily smoking. Genetic factors that influenced nicotine dependence also influenced major 
depression. Major depression was associated with current daily smoking as well as with certain 
nicotine withdrawal symptoms. Subjects that had a familial vulnerability towards major 
depression, even without a personal history of major depression, were more likely to smoke 
despite a serious illness and were more prone to report restlessness, nervousness, difficulty 
concentrating, and depressed mood during past attempts to quit smoking. 
 Munafo, Hitsman, Rende, Metcalfe, and Niaura (2008) aimed to investigate the 
relationship between smoking status and continuous depressed mood within a cohort of 
adolescents. A subset of adolescents was chosen that reported never having smoked a cigarette at 
baseline, some of whom progressed to smoking at a follow up one year later. Data were drawn 
from the National Longitudinal Study of Adolescent Health, an ongoing study to assess the health 
status of adolescents, to explore the causes of adolescent health-related behavior (n = 12,149). 
The subsample that reported never having smoked a cigarette at baseline (n = 5,475) was, on 
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average, 15 years old. The CES-D was used to measure depressed mood. Various findings 
showed relationships between smoking status and depressed mood, with a general trend for these 
effects to be greater in females. Among “never smokers” at baseline, level of depressed mood at 
baseline predicted subsequent progression to smoking initiation (p = .022), but not progression to 
regular smoking (p = .229). Interestingly, among “never smokers” at baseline, progression to 
smoking initiation during the follow-up period was associated with higher CES-D scores at 
follow up, even after adjusting for baseline depressed mood (p < .001), with this effect being 
greater for females than males. Among subjects who initiated smoking, progression to regular 
smoking was associated with higher CES-D scores for follow up among females (p = .966). The 
relationship between cigarette smoking and depression may be a factor in the development of 
subsequent dependence. 
 Husky, Mazure, Paliwal, and McKee (2008) tried to determine if smoking behavior was 
associated with current or lifetime major depression and whether the association was greater in 
women. Data were extrapolated from the National Epidemiologic Survey on Alcohol and Related 
Conditions (NESARC: wave 1, from 2001-2002, n = 42,565). Logistic regression was used to 
examine the relationship between smoking status (daily, occasional, prior) and Diagnostic and 
Statistical Manual IV (DSM-IV) major depression (current and lifetime) by gender in terms of 
odd ratios. The results showed that current (daily, occasional) and prior smoking significantly 
increased the odds of having current or prior major depression. Women with prior smoking 
history were at a significantly higher risk of current or past depression than were men (OR: 1.53 
vs. 1.36; 1.72 vs. 1.36), as was true for current occasional (OR: 1.92 vs. 1.39; 1.90 vs. 1.30) and 
daily smoking (OR: 2.52 vs. 1.95; 1.84 vs. 1.48). It appears that the association between smoking 
and current or past depression is not necessarily limited to smoking that meets the criteria for 
nicotine dependence, and is more potent in women. 
 The literature seems to suggest that individuals that currently smoke or have a past 
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history of smoking are at greater risk for depression than their nonsmoking counterparts (Almeida 
& Pfaff, 2005; Lyons et al., 2008). Furthermore, the risk for depressive symptoms seems to be 
even greater in women than it is in men, whether they are current smokers or past heavy smokers 
(Husky et al., 2007; Munafo et al., 2008). 
History of CHD/MI 
 Following a cardiac event such as an MI, depression can become very common and can 
develop anywhere from 3, to 12, to even 18 months after the event. Depression after an MI can 
have influence on QOL, medical compliance, and cardiological prognosis (Krzyzkowiak, 2007).  
 Lehto et al. (2000) studied the prevalence of depression at least six months after various 
CHD events and the association between depression and certain clinical variables. In their study, 
414 patients (284 males, 130 females) younger than 71 years (mean age for men 60.9 years, and 
for women 63.6 years) were interviewed and examined for smoking habits, BMI, lipid levels, and 
diabetic status. The Depression Scale (DEPS) was used to screen patients for depression. The 
NYHA Class was also assessed. Among these groups, one-sixth, or 14-19% of the patients, 
suffered from depression. 
 Romanelli, Fauerbach, Bush, and Ziegelstein (2002) conducted a study four months after 
a patient was discharged from the hospital with certain cardiac diagnoses. Of the participants, (n 
= 284) who had an acute MI, 153 (53.9%) of these were aged 65 years and older. One hundred 
and one of these (66.0%) actually completed the four-month follow-up interview. One of the 
findings was that older patients with depression were more likely to have had a prior MI than 
older patients without depression (54.3% vs. 31.0%, p = .012). 
 Dickens et al. (2004) conducted a study to consider whether the causes of depression 
occurring before and after MI were similar to those of depression in the general population. 
Consecutive patients admitted to the hospital following a first MI were interviewed with the 
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Schedule for Clinical Assessment in Neuropsychiatry in order to detect psychiatric disorders and 
the Life Events and Difficulties Schedule to assess recent stress. Patients also completed the 
Hospital Anxiety and Depression Scale (HADS) at entry to the study and then one year later and 
the risk factors associated with a high score at both times were assessed. Of 314 patients (88% of 
those eligible) that were recruited, 199 (63%) were male and 63 (20%) had depressive disorders. 
Logistic regression identified the following as independently associated with depressive disorder 
that had been present for at least one month prior to the MI: younger age, past psychiatric history, 
female gender, social isolation, and lack of a close confidant regarding marked non-health 
difficulties. Upon follow up, 269/298 (90%) had responded; of 189 participants that were not 
depressed at the first assessment, 39 (21%) became depressed at the one-year follow up. Logistic 
regression identified frequent angina as the only significant predictor of a raised HADS score at 
12 months. The risk factors that precede an MI may not be the same as those that come after an 
MI, but a link definitely exists connecting the development of depression following an MI. 
 Krzyzkowiak (2007) conducted a study to assess depressive symptom intensity after an 
MI, amongst other variables. The Mini International Neuropsychiatric Interview, BDI, Social 
Readjustment Rating Scale, and Recent Life Changes Scale were used to assess depression in 102 
patients following MI. Of these patients, 10.8% were diagnosed with clinical (major) depression. 
However, depressive symptoms were present in 40%. 
 Kaptein et al. (2006) conducted a study to identify the presence of depressive symptoms 
in patients after an MI. Data were retrieved from the Depression after Myocardial Infarction 
(DepreMI) study, a naturalistic follow-up study of patients that were admitted to four hospitals in 
the Netherlands for MI (n = 475). The BDI was administered during hospitalization, and then at 
3, 6, and 12 months post-MI. The prevalence of significant depressive symptoms ranged form 
22.7% to 25.5% throughout the post-MI year. Five distinct courses were identified: no depressive 
symptoms (56.4%), mild depressive symptoms (25.7%), moderate and increasing depressive 
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symptoms (9.3%), significant but decreasing symptoms (4.6%), and significant and increasing 
depressive symptoms (4.0%). 
 Parakh, Thombs, Fauerbach, Bush, and Ziegelstein (2008) conducted a study to 
determine if depression during hospitalization for MI was associated with mortality and if this 
risk persisted over a longer period of time. Major depression and dysthymia were assessed using 
the structured interview for Diagnostic and Statistical Manual of Mental Disorders, Revised, 
Third Edition, and depressive symptoms, using the BDI. The subjects included 284 patients that 
were hospitalized for MI. Any type of depression (major, dysthymia, and/or BDI score of > 10) 
was discovered in 76 (26.8%) patients. 
 Based on the literature, it appears as though depression is very common in patients that 
have experienced an MI. Throughout the studies, it seems as though the percentages of depressed 
patients is consistently above 20% (Dickens et al., 2004; Kaptein et al., 2006; Krzyzkowiak, 
2007; Parakh et al., 2008). Even more importantly, the course of depression does not always 
diminish over time. In many cases the course of depression increases. In some cases those that 
were not depressed at the time of discharge from the hospital were found to be depressed at their 
one-year follow up (Dickens et al., 2004). 
Social Isolation/Social Support 
 Depression and social isolation/poor social support affect one in seven people over the 
age of 65. There is increasing evidence that these factors can adversely affect long-term health. 
Interventions that promote social contact, and encourage creativity are likely to promote better 
health and overall well-being (Januzzi & Pasternak, 2002).  
 Greaves (2006) conducted a study to evaluate a complex intervention for addressing 
social isolation in older people. Mentors delivered a series of individually tailored activities. 
These activities were tapered off over time. Two hundred and twenty-nine participants at the 
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Upstream Healthy Living Center were offered the Geriatric Depression Scale (GDS), SF12 
Health Quality of Life, and Medical Outcomes Social Support Scale at baseline. These same 
assessments were offered at 6 and 12 months post intervention. Data were available for 172 
(75%) participants at baseline, 72 (53% of those eligible) at 6 months and 51 (55%) at 12 months. 
Baseline scores indicated social isolation and high morbidity for physical and mental health. The 
intervention was successful in engaging this population (80% participated in some form of 
activity). At 6 months there were significant improvements in the SF12’s mental component and 
the depression scores, but not in perceived physical health or social support. At 12 months, there 
were significant improvements in depression and social support but only a marginally significant 
improvement in SF12’s physical component (p = .06); however, the SF12 mental component was 
not maintained. Interestingly, the data showed a wide range of responses, both emotional and 
physical. The responses included increased mental alertness, social activity, self worth, optimism 
about life, and positive changes in health behavior. 
 Xie et al. (2005) studied the effects of peer isolation and social support availability on the 
relationship between BMI and depressive symptoms. Baseline data were gathered from 1,655 
Chinese adolescents between 11 and 15 years of age. Information was retrieved from a 
longitudinal smoking cessation and health promotion program in Wuhan, China. Assessments of 
height and body weight, depressive symptoms, perceived peer isolation (PPI), and perceived 
availability of social support (PASS) were gathered. According to the International Obesity Task 
Force (IOTF) age and sex specific BMI cutoffs, 12.5% of the boys and 9.2% of the girls were 
overweight. Among the girls, high BMI was significantly related to higher self-reported 
depressive symptoms, and was primarily mediated by PPI. On the contrary, high BMI boys 
reported significantly lower levels of PPI, although high PPI level definitely increased depressive 
symptoms. In both boys and girls, the observed effect of PPI on the relationship between BMI 
and depressive symptoms was only sustained in low-PASS girls and boys. This study reveals that 
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there are differences in boys and girls relating to the effects of PPI on the association of BMI and 
depressive symptoms, which was buffered only by levels of PASS. 
 Vanderhorst and McLaren (2005) studied the human relatedness of variables such as 
social support resources, marital status, and sense of belonging as predictors of depression and 
suicidal ideation in older adults. A community sample of 110 older adults with a mean age of 
76.67 years, SD = 811, was used. They each completed the Social Support Subscale of the 
Coping Resources Inventory, the Sense of Belonging Instrument, the Zung Depression Inventory, 
and the Suicide Subscale of the General Health Questionnaire. The results showed that fewer 
social support resources were associated with higher levels of depression and suicidal ideation. 
Interestingly, the researchers found that sense of belonging was not a good predictor of mental 
health. 
 Steptoe, Owen, Kunz-Ebracht, and Brydon (2004) conducted a study to determine if 
loneliness, which is related to social isolation and perceived lack of companionship, is a health 
risk. The revised UCLA loneliness scale was completed by 240 working men and women aged 
47-59 years. This scale was related to affective state and cardiovascular, neuro-endocrine, and 
inflammatory processes. The loneliness scores were not associated with age, gender, or 
socioeconomic status, but were lower in married participants than in divorced or single 
participants. These scores were positively related to social isolation, low emotional support, 
hopelessness, ratings of depression, low self esteem, and sleep problems. Lonely individuals 
displayed a significantly higher level of fibrinogen (p = .038). The cortisol levels in lonely 
individuals were elevated within the first 30 minutes after awakening, even after adjusting for 
waking cortisol value, sex, socioeconomic status, smoking, time of waking, and body mass (p = 
.046). The authors concluded that loneliness is a psychological experience that has potentially 
negative effects on our biological stress responses and could very well be detrimental to one’s 
health.  
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 Wang, Mittleman, Leineweber, and Orth-Gomer (2006) conducted a study to examine the 
joint effects of depressive symptoms and social isolation regarding the progression of 
atherosclerosis in women. There were 102 women enrolled in the Stockholm Female Coronary 
Angiography Study in Sweden between 1991 and 1994. Coronary atherosclerosis progression was 
evaluated by using a computer-assisted standardized assessment. This assessment looked at the 
mean luminal diameter change in the artery over 3 years in a series of 10 predefined coronary 
segments. Social isolation and depressive symptoms were assessed by using standard 
questionnaires. Multivariable controlled mixed model ANOVAs showed that women who were 
both depressed and socially isolated had the greatest amount of disease progression. Their 
absolute mean luminal diameter decreased by 0.18 mm (95% CI = .11-.24) and their percent 
narrowing was 5.5% (95% CI = 3.6-7.4). In women who had neither psychological factor, the 
mean luminal diameter decrease was 0.04 mm and their narrowing was 0.9%. It would appear 
that in women with coronary disease, depressive symptoms, and social isolation combined, the 
disease process was accelerated. This seems to suggest a direct psychological effect on the 
atherosclerotic process. 
 Choi and McDougall (2007) conducted a study to compare homebound older adults to 
their ambulatory peers who attended senior centers with respect to their depressive symptoms, 
depression risk and protective factors, and self-reported coping strategies. There were 81 low-
income, homebound older adults, compared to 130 ambulatory older adults that attended a local 
senior center. Even when controlling for socio-demographics, health problems, and other life 
stressors, being homebound, as compared to attending a senior center, was significantly 
associated with higher depressive symptoms. Interestingly, however, when coping resources—
social support and participation in frequent physical exercise—were added to the regression 
model, the homebound situation was no longer a significant factor. 
 Boden-Albala, Litwak, Elkind, Rundek, and Sacco (2005) conducted a study to assess the 
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relationship between social isolation and stroke outcomes in a multiethnic cohort. The authors 
prospectively followed 655- ischemic stroke cases for 5 years. The group consisted of 55% 
women, 17% white, 27% African American, 54% Hispanic, and a mean age of 69 +/- 12 years. 
These patients were enrolled in the Northern Manhattan Stroke Study. Baseline data were 
collected regarding social isolation. At their follow-up, the authors documented events as defined 
by the first occurrence of MI, stroke recurrence, or death. Cox hazard models were used to 
calculate the hazard ratio (HR, 95% CI) for pre stroke predictors for post stroke outcomes. The 
results showed that there were 265 first-outcome events. Using univariate analysis, coronary 
artery disease (OR 1.3, 1.0-1.7), age >70 years (OR 1.9, 1.5-2.5), atrial fibrillation (AF) (OR 1.8, 
1.3-2.5), race-ethnicity (white vs. Hispanic) (OR 1.7, 1.1-2.9), physical inactivity (OR 1.3, 1.1-
2.6), help at home (OR 1.8, 1.4-2.4), and social isolation (OR 1.4, 1.2-1.6) were associated with 
an increased risk of an outcome event. It appears that pre stroke social isolation is a predictor of 
outcome events post stroke. 
 Schiffer et al. (2005) aimed their study to discover if Type D personality was associated 
with an impaired health status and increased depressive symptoms in patients with CHF, 
independent of disease characteristics. Patients (n = 84, 63 men and 21 women), with systolic 
CHF completed four different questionnaires to assess Type D personality (14-item Type D 
Personality Scale [DS14]), health status (Minnesota Living with Heart Failure Questionnaire 
[MLWHFQ]), depressive symptoms (Center for Epidemiological Studies-Depressions [CES-D], 
and mood status (Global Mood Scale [GMS]) upon visiting an outpatient heart failure clinic. 
Patient medical charts were also utilized to obtain certain other clinical variables. The results 
showed that Type D patients were more likely to experience impairment in health status (18/38 = 
47%) as compared to non Type Ds (11/46 = 24%), (p = .027). These same Type D patients also 
reported more depressive symptoms than the non-Type Ds (18/38 = 47% vs. 6/46 = 13%, p = 
.001). Even when controlling for severity and etiology of CHF, age, and gender, Type D 
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continued to be a significant associate of impaired health status (OR 3.0, 95% CI, 1.12-7.78) and 
depressive symptoms (OR 6.3, 95% CI, 2.08-19.12). 
 Karlsson et al. (2007) further discovered that if Type D patients were given more 
expanded cardiac rehabilitation (stress management, increased physical training, staying at a 
“patient hotel” following discharge, and cooking lessons), the outcome was significant. The study 
randomized 224 cardiac patients either to an expanded cardiac rehabilitation program or to a 
traditional, routine cardiac rehabilitation program. These patients were followed up on within one 
year. At baseline, the patients that had a high Type D score, had a lower sense of coherence (p < 
.001), a lower QOL (p < .001), more depressive symptoms (p < .001), and increased anxiety (p < 
.001) as compared to those patients with a low Type D score. After follow up, the Type D 
patients that had been randomized to the expanded cardiac rehabilitation program showed 
significant decreases in their Type D scores (p < .01), depression and anxiety (p < .05), and an 
increment in QOL scores (p < .001). It would appear that an expanded cardiac rehabilitation 
program could have a significant effect on patients that have a Type D personality and improve 
anxiety, depression, and QOL. 
 Given the great amount of research that has been conducted in regard to Type D 
personality and its association to impaired health status (particularly for further risk of CHD), it 
would appear that a great deal of value ought to be placed on including the assessment of 
personality factors when evaluating the cardiac patient (Schiffer et al., 2005).  
Type D Personality 
 Type D personality refers to the tendency to experience negative emotions and to inhibit 
the expression of these emotions in social interactions or relationships (Denollet, Pedersen, 
Vrints, & Conraads, 2006). The “D” stands for ”distressed.” John Denollet, a Dutch professor of 
medical psychology, is the founder of this concept. Research has shown that CHD patients with a 
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Type D personality have a worse prognosis after an MI as compared to patients without the Type 
D personality. Type D personality is associated with four to eight times the increased risk of 
mortality, recurrent MI, or sudden death (Denollet et al., 2006). Type D personality has also been 
associated with increased risk of depression, exhaustion, and social alienation (Pedersen & 
Denollet, 2004). 
 Denollet et al. (1996) postulated that the Type D personality was an independent 
predictor of long-term mortality in CHD. To test this hypothesis, 268 men and 35 women with 
angiographically proven CHD, aged 31-79 years, who were taking part in an outpatient cardiac 
rehabilitation program, were studied. Each patient completed a personality questionnaire at 
entrance to the program. These same patients were contacted 6-10 years later to establish survival 
status. The main endpoint was death from all causes. The results showed that 38 patients had 
died, and of those, 24 were cardiac related deaths. The rate of death was statistically significantly 
higher for Type D patients than for non-Type D patients (33 [27%]/85 vs. 15 [7%]/218; p < 
.00001). Evidence of the association between Type D personality and mortality was still strong 
more than 5 years after the coronary event in both men and women. In this study, mortality was 
associated with impaired left ventricular function, three-vessel disease, low exercise tolerance, 
and the lack of thrombolytic therapy after an MI. Even when controlling for these biomedical 
predictors, using the multiple logistic regression analysis, the impact of Type D personality 
remained significant (OR: 4.1, 95% CI, 1.9 -8.8, p = .0004). Social alienation and depression 
were also related to mortality, but did not have the predictive power of the Type D personality. 
 Denollet et al. (2006) investigated the relative effect of stress and Type D personality 
relating to prognosis at 5-year follow ups. Three hundred and thirty seven patients with CHD who 
were participating in a cardiac rehabilitation program were studied. Patients filled out the General 
Health Questionnaire (to determine psychological stress) and the Type D Personality Scale. 
Patients were followed for 5 years. The end point consisted of major adverse cardiac events. 
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There were 46 major adverse cardiac events at follow up that included four deaths and eight MIs. 
Patients with Type D personality had an increased risk of death/MI (OR: 4.84, 95% CI, 1.42-
16.52, p = .01) compared to non-Type D personality patients, independent of disease severity. 
Stress (p = .011) and Type D (p = .001) were related to increase the risk of developing a major 
adverse cardiac event even after adjusting for gender, age, and biomedical risk factors. 
Multivariate analysis showed left ventricular ejection fraction (EF) ≤ 40%, no treatment with 
CABG, and Type D personality as independent predictors of major adverse cardiac events (OR: 
2.90, 95% CI, 1.4-5.92, p = .003), whereas psychological stress was only marginally significant 
(OR: 2.01, 95% CI, 0.99-4.11, p = .054). Type D personality may well be added to the risk 
stratification of CHD patients. 
 Denollet, Vaes, and Brutsaert (2000) hypothesized that chronic emotional stress creates 
an increased risk for negative outcomes regardless of appropriate treatment. This prospective 
study examined the five-year prognosis of 319 CHD patients. Assessments for depression/anxiety 
and Type D personality were administered at baseline. The main end points included cardiac 
death or nonfatal MI and impaired QOL. Twenty-two cardiac events (nonfatal) occurred. These 
events were related to left ventricular ejection fraction (LVEF) < or = 50% (OR: 3.9; p = .009), 
Type D personality (OR: 8.9, p = .0001), and age < or = 55 years (OR: 2.6; p = .05) as 
independent predictors of cardiac events. The presence of two or three of these risk factors 
occurring simultaneously increased the rate of poor outcome 4-fold (p = .0001). Emotionally 
stressed, younger patients that have a decreased LVEF have an increased risk of cardiac events. 
Furthermore, when these risk factors coexist, a non-response to treatment may occur. Emotionally 
stressed younger patients with CHD represent high-risk groups that deserve more intense study. 
 Van der Broek, Martens, Nyklicek, Van der Voort, and Pedersen (2007) studied the 
emotional influence of not having a partner and its combined effects with Type D personality on 
anxiety and depression. The subjects were patients (n = 554) that were hospitalized for acute 
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myocardial infarction (AMI) or an implantation procedure of a cardioverter defibrillator. These 
patients completed a 14-item Type D Scale (DS14) during their hospitalization and the State Trait 
Anxiety Inventory (STAI) and BDI at a 2-month follow up. The results showed that, stratifying 
by personality and partner status, Type D patients that did not have a partner had a higher risk of 
both anxiety (OR = 8.27, 95% CI, 2.50-27.31) and depressive symptoms (OR = 6.74, 95% CI, 
2.19-20.76) followed by Type D patients that did have a partner (OR = 2.04, 95% CI, 1.05-3.96 
and OR = 3.03, 95% CI, 1.46-6.31, respectively). It would seem that lack of a partner further 
exacerbates the risk of symptoms of anxiety and depression in the already identified Type D 
patient. 
 Pedersen, Denollet, Van Gestel, Serruys, and Van Domburg (2008) decided that the 
single factor approach to studying their influence on health outcomes in cardiac patients might 
not be giving the full picture. The impact of clustering was examined (Type D personality and 
anxiety) on depressive symptoms 12 months following percutaneous coronary intervention (PCI). 
Patients that had been treated with PCI (n = 416) with drug eluting stents, were asked to complete 
the Type D Scale and the Hospital Anxiety and Depression Scale anxiety subscale at baseline, 
and the depression subscale at 12 months follow up. The results showed that of all these patients, 
27% experienced depressive symptoms at 12 months. Depression could not, however, be 
attributed to cardiac events that had occurred during follow up (p = .76). The prevalence of 
depressive symptoms at 12 months was the highest in patients that had clustering (64%), followed 
by the single risk factor of Type D (45%), and anxiety (38%). The lowest prevalence was in the 
“no risk factor” group (13%; p = .001). The “single risk factors” Type D personality (OR = 5.82, 
95% CI, 2.93-11.56) and anxiety (OR = 4.36, 95% CI, 2.23-8.55) and their co occurrence (OR = 
12.38, 95% CI, 6.11-25.09) remained independent significant predictors of depressive symptoms 
at 12 months compared with the “no risk factor” group. Patients that have a co-occurrence of 
anxiety and Type D personality, which are two risk factors that are independently associated with 
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adverse prognosis, had a considerably higher risk of depressive symptoms 12 months post PCI 
compared with patients with no or just one risk factor. 
 The literature would suggest that depression and Type D personality have both been 
associated with worse outcome and prognosis for cardiac patients, but De Jonge et al. (2007), 
were concerned that the link between depression and cardiac prognosis could be confounded by 
somatic health. The association between depressive disorder and Type D personality was studied 
based on an individual’s baseline somatic health. Post-MI patients (n = 1,205) from the 
Myocardial Infarction and Depression Intervention Trial study were assessed according to the 
ICD-10 criteria with the Composite International Diagnostic Interview during the post-MI year 
and Type D patients with the DS14 at one year follow up. Somatic health was determined by left 
ventricular ejection fraction (LVEF), Charlson Comorbidity Index, previous MI, and CABG or 
percutaneous transluminal coronary angiography (PTCA). The results showed that the prevalence 
rates were 17.1% for post-MI depression and 18.7% for Type D. After controlling for 
confounders, post-MI depression was associated with lower baseline LVEF (OR = 3.17, 95% CI, 
2.28-4.41) and greater co morbidity (OR = 1.46, 95% CI, 1.02-2.09), whereas Type D personality 
was not (LVEF: OR = 1.31, 95% CI, 0.93-1.87) and (comorbidity: OR = 0.92, 95% CI, 0.63-
1.35). It would appear that post-MI depression is more related to somatic health and symptoms 
than Type D personality at 12-month follow up.  
 Literature exists primarily in favor of the Type D personality as it relates to increasing the 
risk for developing depressive symptoms (Denollet et al., 1996, 2000, 2006; Pedersen et al., 
2008). Interestingly, Denollet was an integral part of most of the studies that were for or against 
the assumptions that were exerted about Type D personality. Pedersen et al. (2008) suggested that 
clustering of risk factors may have even greater impact than single risk factors and De Jonge et al. 
(2007) asserted that somatic health played a more integral part in depressive symptoms than Type 
D personality. It would appear that more research is needed, but that Type D personality is a 
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concept that will be shown to have its part in the development of depressive symptoms for cardiac 
patients. 
Gender 
 Gender differences in depression have been documented for several years and have only 
recently been thought to be important in the treatment selection for the depressed patient. Some 
general explanations for the male-to-female sex ratio in the prevalence of depression might 
include: psychological, neuro-chemical, anatomic, hormonal, genetic, and personality factors. 
Hormonal status may play an important role in addition to effects from the menstrual cycle, 
pregnancy, peri-menopause, and menopause (Grigoriadis & Robinson, 2007). 
 Romans, Tyas, Cohen, and Silverstone (2007) collected data from the Canadian 
Community Health Survey 1.2 for gender analysis of individual symptoms and overall rates of 
depression in the preceding 12 months. MDD was assessed by using the Composite International 
Diagnostic Interview. This represented a national, cross-sectional survey. Interestingly, the 
female to male ratio of MDD prevalence was 1.64:1 (n = 1766). Women reported statistically 
more depressive symptoms than men (p < .001). 
 Zinn-Souza et al. (2008) conducted a study to assess factors associated with symptoms of 
depression within a high school-aged sample (14-18 years). Seven hundred and twenty four 
students answered questionnaires based on life and health conditions. Factors associated to 
depressive disorders were analyzed by using multiple logistic regression. The results showed that 
over all, the prevalence rate of depression was 7.5%. These rates were divided into gender and 
found that 39 (10.3%) were females and 15 (4.3%) were males. Multiple logistic regression 
analysis showed that the factors associated with depressive disorders were being female (OR = 
2.45), poor self-perception of health (OR = 5.78), and alcohol consumption (OR = 2.35). 
 Ryan et al. (2008) studied the relationship between gender and depression when 
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antidepressant mediations were used. Method-adjusted Cox proportional hazards models were 
used to determine the association between depression and/or antidepressant use and 4-year 
survival in 7,363 community-dwelling elderly people. MDD was evaluated using DSM-IV 
criteria. Depressive symptoms were assessed using the CES-D. The results showed that mortality 
was the greatest in depressed men using antidepressants with increasing severity correlating to a 
higher hazard risk. Women with severe depression in the absence of treatment, on the other hand, 
had the strongest association with mortality. The conclusions show that the association between 
mortality and depression is gender-dependent and can vary in accordance with antidepressant use 
and symptom-load. 
 Danielsson and Johansson (2005) conducted a qualitative study to examine and explore 
depression from a gender perspective. They worked to capture depressed men’s and women’s 
formulations of their experiences and their particular understanding of the situation. The study 
took place in a healthcare center in northern Sweden. The subjects consisted of 18 patients that 
had been diagnosed with depression and had been treated for the depression for at least 6 months. 
The patients were of different ages and social status. These patients were interviewed in depth. 
Questions were posed and were based on the themes of Malterud’s key questions. The focus was 
especially on how the informants conveyed their experiences. The results showed that the 
experience of depression was similar for men and women, but the outward manifestations 
differed by gender as well a socioeconomic status. Men spoke more easily about physical distress 
than emotions. Women spoke more readily about emotional distress, shame, and guilt, while 
physical symptoms tended to revolve around the stomach. Men dealt with insecurity by 
aggrandizing their previous competence. Women dealt with insecurity by self-effacement. The 
authors felt that clinicians must listen carefully to not only the words spoken but to the avoided 
words. This could help to counteract the normative gender patterns that highlight depression of 
women and tend to conceal that of men.   
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 Gender and depression is also a highly studied issue as it relates to the cardiac patient. 
Westin, Carlsson, Erhardt, Cantor-Graae, and McNeil (1999) conducted a study in Sweden from 
1989-1992 to evaluate the differences in QOL in male and female patients after AMI, CABG, and 
percuataneous transluminal coronary angioplasty (PTCA). Psychological and somatic dimensions 
of QOL were assessed by self-report questionnaires in these patients at one month (n = 376) and 
one year (n = 349) following the cardiac event. Normal controls were used for comparison (n = 
88). The results showed that female patients had a poorer QOL after 1 month (in depression, 
feeling of arrhythmia, anxiety, general health, self-esteem, and experience of sex life), and after 1 
year as compared to their male counterparts.  
 Heo, Moser, and Widener (2007) also studied the health-related quality of life (HRQOL) 
in cardiac patients. The aim of the study was to investigate whether the gender might affect 
HRQOL in patients with heart failure (HF). Data were collected from 51 men and 47 women. The 
data were analyzed using regression analyses. The authors found no gender differences in the 
dynamic relationships among the variables in physical or emotional symptom status, or HRQOL, 
but there were differences found in the relationships between other dynamic variables. Using 
bivariate analyses, physical and emotional symptoms status was found to be related to HRQOL in 
both men and women. However, in women, HRQOL was related to physical symptom status, 
while in men depression affected HRQOL in multivariate analyses (p < .001, r(2) = .27; p < .001, 
r(2) = .40, respectively). Functional status as measured by the NYHA Class mediated the effects 
of anxiety and depression on HRQOL only in women. 
 Verhagen et al. (2008) went a step further to examine if familiality of MDD could 
contribute to observed gender differences in comorbidity. Familial (f-MDD) and non-familial 
MDD (n-MDD) cases were studied. This population sample was assessed for co morbid 
dysthimia, anxiety disorders, and alcohol related disorders. The Composite International 
Diagnostic Interview (CIDI) was used to assess this. Logistic regression analyses showed that 
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women with f-MDD reported a significantly higher amount of comorbid dysthymia and 
generalized anxiety disorder (GAD) than their male counterparts. Women that had n-MDD 
reported significantly more comorbid simple phobias and agoraphobia than their male 
counterparts. The authors concluded that models that explain comorbidity patterns of MDD do 
differ by gender. 
 Faller et al. (2007) went a step further to see if the influence of depression on health 
outcomes in heart failure patients could be affected by gender differences. At entrance to the 
study, depression was measured using a self-reported PHQ (n = 231). The median follow-up time 
was 986 days. The results showed that suspected major depression was identified in 13% of 
patients. Minor depression was identified in 17% of patients. Interestingly, no differences 
between the sexes were discovered. Major, but not minor, depression was associated with 
increased mortality risk (HR = 3.3, 95% CI, 1.8-6.1, p = < .001). The authors concluded that there 
is definitely a high prevalence of depression in the heart failure patient, but when testing the 
effect of interaction between depression and gender, statistical significance failed to be reached. 
 Naqvi et al. (2007) examined the influence of gender on the prevalence of ACS and the 
severity of depressive symptoms post-ACS. Nine hundred and forty four (716 men and 228 
women) patients were surveyed using the Zung self-assessment questionnaire at discharge 
following unstable angina (UA) or ACS. Patients were asked to return the questionnaire by mail. 
Major depressive symptoms were diagnosed using a summed depressive symptoms (SDS) score 
> 50. Of these patients, 250 (35%) men, and 103 (45%) women had depressive symptoms (p = 
.005). Depression was modeled by stepwise multivariable logistic regression using the following 
predictors: gender, age, hypertension, diabetes mellitus, history of smoking, 
hypercholesterolemia, peripheral vascular disease, prior stroke, prior MI, and prior percutaneous 
coronary intervention (PCI), or CABG. The significant predictor of depressive symptoms being 
present were female gender (OR = 1.64, 95% CI, 1.19-1.28), diabetes mellitus (OR = 1.42, CI 
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95%, 1.03-1.97), prior MI (OR = 1.56, 95% CI, 1.15-2.20), and smoking (OR = 1.41, 95% CI, 
1.01-1.97). The variables that were associated with a higher severity of depressive symptoms 
were female gender, prior MI, smoking, and stroke. It was discovered that men who had prior MI, 
had higher SDS scores than men without prior MI (48.4 vs. 44.6, respectively, p = .001). 
Interestingly, prior MI did not seem to affect SDS scores in women (49.1 for prior MI vs. 48.5 for 
no prior MI). Depressive symptoms were more severe in women with UA (SDS = 49.0) 
compared with women with AMI (SDS = 45), or men with AMI (SDS = 45.0, p = .004) or UA 
(46.0, p = .007). Although female gender is a significant independent predictor of depressive 
symptoms post-UA and MI, in women, a history of MI is associated with a higher frequency of 
depressive symptoms than in men. 
 The current evidence suggests that depression appears to cause a higher increase in 
coronary artery disease (CAD) in women, and that women CAD patients do experience greater 
levels of depression than men (Moller-Leimkuhler, 2007). It appears that whether one researches 
gender and depression from a non-specific view or from a disease-specific view (i.e., CHD), 
gender does seem to play a large role (Heo et al., 2007; Romans et al., 2007; Zinn-Souza et al., 
2008). Very few studies show any indication of non-significance (Faller et al., 2007). 
Furthermore, when familial MDD is factored in, co morbid dysthymia is even greater in women 
than in men (Verhagen et al., 2008). 
NYHA Class/Disability 
 In 1928, the NYHA published a classification system for cardiac patients based on 
clinical severity and prognosis. These classifications have been updated in seven subsequent 
editions. The ninth, and most current, edition was revised by the Criteria Committee of the 
American Heart Association, New York City Affiliate (see Table 1). The class is defined by an 
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individual’s functional capacity. The classes range from I to IV, with IV representing the lowest 
functional capacity. There is also an objective assessment component that is addressed by the 
 
Table 1 
Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels 
Functional capacity Objective assessment 
Class I.  Patients with cardiac disease but without 
resulting limitation of physical activity.  Ordinary 
physical activity does not cause undue fatigue, palpation, 
dyspnea, or anginal pain. 
No objective evidence 
cardiovascular disease. 
Class II.  Patients with cardiac disease resulting in slight 
limitation of physical activity. They are comfortable at 
rest. Ordinary physical activity results in fatigue, 
palpitation, dyspnea, or anginal pain. 
Objective evidence of minimal 
cardiovascular disease. 
Class III.  Patients with cardiac disease resulting in slight 
limitation of physical activity.  They are comfortable at 
rest.  Less than ordinary activity causes fatigue, palpation, 
dyspnea, or anginal pain. 
Objective evidence of moderately 
severe cardiovascular disease.  
Class IV.  Patients with cardiac disease resulting in 
inability to carry on any physical activity without 
discomfort.  Symptoms of heart failure or the anginal 
syndrome may be present even at rest.  If any physical 
activity is undertaken, discomfort is increased. 
Objective evidence of severe 
cardiovascular disease. 
Adapted from The Criteria Committee of the New York Heart Association, 1994. 
 
health care provider-based measurements taken such as electrocardiograms, stress tests, x-rays, 
echocardiograms, and radiological images (The Criteria Committee of the New York Heart 
Association, 1994).  
This classification is used most often in patients who have CHF. Depression is common 
in this group of patients and is associated with poor QOL. Much research has been devoted to 
understanding how NYHA Class affects depressive symptoms in these patients. Moser, Doering, 
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and Chung (2005) conducted a study to look at the multiple risk factors that increased re-
hospitalizations for patients being discharged with heart failure. Two hundred and two patients 
were evaluated for the following potentially modifiable risk factors: functional status, if patient 
lived alone, presence of depression, anxiety, poor QOL, symptom status and adherence to 
prescribed medications, symptom monitoring, and low-sodium diet. A good portion of these 
patients were severely functionally impaired (70% NYHA class III/IV). Of these patients, 69% 
were depressed. 
 Scherer et al. (2007) conducted a study to analyze depression and/or anxiety in primary 
care patients that had heart failure. They also tried to identify protective factors to help resolve 
these psychosocial distresses. The study was a longitudinal observation study in primary care 
practices in lower Saxony, Germany (n = 291). Depression and anxiety were assessed using the 
Hospital Anxiety and Depression Scale (HADS). Severity of heart failure was assessed using the 
NYHA classification system. The results showed that 26 (32.5%) of those patients that were 
distressed at baseline had a normal HADS score 9 months later. The rest of these patients 
remained distressed. Using logistic regression, baseline distress (OR 5.51%; 95% CI = 2.56 - 
11.62), emotional problems (OR 1.08; 95% CI = 1.00 - 1.17), social support (OR 0.54; 95% CI = 
.35 - .83), and NYHA classification (OR 1.70; 95% CI = 1.05 - 2.77) independently predicted 
distress at follow up. High social support aided in the resolution of depression and anxiety and 
partnership and low levels of emotional problems protected patients that had started the study in a 
good emotional state. This study suggests that high NYHA class and emotional problems may 
contribute to depression and anxiety. 
 Freedland et al. (2003) conducted a study to investigate the prevalence of depression in 
682 hospitalized heart failure patients. The study also identified demographic, psychosocial, 
medical, and methodological factors that might affect prevalence. A modified version of the 
DSM-IV was administered to these patients to identify major and minor depression. Six hundred 
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and thirteen of these patients also completed the BDI. The medical, demographic, and social data 
were obtained through hospital chart review, patient interview, and echocardiography. In this 
particular sample, 20% of the patients met DSM-IV criteria for current MDD, and 51% scored 
higher than the cutoff for depression using the BDI (> or = 10). Interestingly, the prevalence of 
MDD differed significantly between the functional severity of the heart failure (NYHA class), 
gender, age, employment status, past history of MDD, and dependence in activities of daily living 
(ADL). The prevalence of depression ranged from as low as 8% in patients that had a NYHA 
class of I, to as high as 40% in patients that had NYHA class of IV.  
 Pihl, Jacobsson, Fridlund, Stromberg, and Martensson (2005) wanted to determine if 
older patients suffering with heart failure and their spouses experienced similar levels of 
depression. Data were collected from 47 couples. The Zung Self-rating Depression Scale (SDS) 
and the Short Form 36 (SF-36) were used. The results showed that patients suffering from heart 
failure, along with their spouses, did not differ significantly in their mental health. Physical 
symptoms primarily dominated the experience of the depressive experience of the patient, which, 
in turn, affected the spouse accordingly. The patient’s depression was positively related to NYHA 
class, while the spouse’s depression was related more with the higher age of the patient. 
 Jiang et al. (2001) conducted a study to determine the prevalence of depression in  
hospitalized CHF patients that were in the NYHA Class II or greater. The patients were all 18 
years of age and older, had an ejection fraction of 35% or less, and were admitted between March 
1, 1997, and June 30, 1998 to a cardiac care unit. Patients were given the BDI to assess 
depression. If a patient scored 10 or greater, they underwent a modified National Institute of 
Mental Health Diagnostic Interview Schedule to assess for MDD. All cause mortality and 
readmission rates were assessed. Of 374 patients screened, 35.3% had a BDI score of 10 or 
greater, and 13.9% had MDD.  
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 Gott et al. (2006) studied the factors predictive of QOL amongst older people that had 
heart failure. Five hundred and forty two patients aged over 60 years with heart failure were 
recruited from community general practice surgeries. Patients completed a postal questionnaire 
that included disease-specific questions (Kansas City Caridomyopathy Questionnaire), a generic 
QOL questionnaire (SF-36), and provided sociodemographic information. A multiple linear 
regression analysis identified the following factors as predictors of decreased QOL: NYHA 
functional class III or IV, evidence of depression, female, lower socioeconomic group, and two or 
more medical comorbidities. 
 Westlake, Dracup, Fonarow, and Hamilton (2005) conducted a study to describe the 
prevalence of depression in patients with heart failure and the differences between patients with 
minimal versus mild to severe depression. The data were collected from 200 patients having 
symptoms of heart failure that resulted from systolic dysfunction. These patients were, on 
average, 57.0 (+/- 12.1) years old, male (168, 84%), and in the NYHA functional class II or III (n 
= 140, 70.0%), with a mean ejection fraction (EF) of 25.5 +/- 6.4%. Minimal depression was 
described by 105 (52.5%) patients, mild depression was described by 62 (31%) patients, moderate 
depression was described by 30 (15%) patients, and severe depression was described by 3 (1.5%) 
patients. The significant differences between patients with minimal depression compared to mild 
to severe depression, were NYHA class (chi2 = 14.05, p = .003), maximal oxygen uptake (t = 
2.62, p = .010), 6 minute walk distance (t = 4.22, p < .001), beta blocker therapy (chi2 = 15.21, p 
< .001), perceived control (t = 7.93, p < .001), and neuroticism (t = -8.85, p < .001). 
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The Prevalence of Depression  
in the Cardiac Patient 
 The prevalence of depression in the cardiac patient can range anywhere from 15-65% 
(Amin et al., 2005; Feinstein et al., 2006; Hermann-Lingen, 2001; Kaptein et al., 2005).  Many 
studies exist that include statistics specifying the prevalence of depression in the patient with 
CHD (Carney et al., 1996; Goldstein, 2006; Hermann-Lingen, 2001; Lane et al., 1999; Thornton, 
2001). For instance, evidence suggests that depression experienced after an MI is not transient. At 
3 months follow up, 77% of patients who met the criteria for major depression still showed 
evidence of depression (Lane et al., 1999). Data from epidemiological surveys suggest that the 
typical cardiologist doing rounds on a 25-bed unit will see four patients with major depression 
and five with a minor form of depression (Lesperance & Frasure-Smith, 2000). The occurrence of 
depression before and after CABG surgery was 53% at one month after surgery and 47% at one 
year. In patients that were not depressed before CABG surgery, 13% were depressed at one 
month and 9% were depressed at one year (Lane et al., 1999). Of 430 patients with unstable 
angina, 41% were identified as depressed (Goldstein, 2006). 
 Following Hospitalization for MI 
 Frasure-Smith (2000) conducted a study that initially interviewed 222 MI patients from 5 
to 15 days following their admission to the hospital. Forty-seven percent of these patients met 
criteria for major depression either by the DSM-III-R or BDI scores. Of those who met criteria at 
6 months follow up, 5% of these patients had died, and half of them had major depression; this 
suggests a relative risk associated with the depression of 4.29 (95% CI, 3.14-5.44) after 
controlling for other clinical variables (Killip class, previous MI, and prescription of Warfarin at 
discharge). 
 Murphy et al. (2008) conducted a study to examine different trajectories of anxiety and 
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depression after an AMI in the 12 months following their cardiac event. A sample of 226 women 
was interviewed using the Hospital Anxiety and Depression Scale (HADS) on four separate 
occasions. These women had experienced either an AMI or CABG. Growth curve and growth 
mixture modeling was used in order to identify trajectories of change, and univariate tests were 
used to discover predictors of each trajectory. In general, most of these women began with 
relatively low levels of anxiety and/or depression. These conditions improved over the 12-month 
period of follow up (84% of women showed this trajectory for anxiety and 89% showed this 
trajectory for depression). Interestingly, a smaller group began with relatively high levels of 
anxiety and/or depression that actually got worse over time (16% for anxiety and 11% for 
depression). The patients in the high level group were more likely to report high levels of 
loneliness, to not have English as a first language, to perceive their cardiac disease as more severe 
(anxiety group only) and have diabetes (depression group only).  
 Kaptein et al. (2006) conducted a study to classify MI patients according to their specific 
course of depressive symptoms and to then evaluate their cardiac prognosis. In the process, much 
was discovered about the prevalence of depression in these patients. Data were derived from the 
Depression after Myocardial Infarction (DepreMI) study. This study was a naturalistic follow-up 
study of patients that were admitted with an MI to four different hospitals in the Netherlands 
during September 1997 and September 2000 (N = 475). The BDI was administered to patients at 
3, 6, and 12 months post-MI and was then analyzed. From the analyses, it was discovered that the 
prevalence of significant depressive symptoms ranged anywhere from 22.7% to 25.5% during the 
post-MI year. Five distinct courses were identified: no depressive symptoms (56.4%), mild 
depressive symptoms (25.7%), moderate and increasing depressive symptoms (9.3%), significant 
but decreasing symptoms (4.6%), and significant and increasing symptoms (4.0%). Incidentally, 
patients in the last class identified, had a statistically significantly higher risk for a new 
50 
cardiovascular event compared to subjects without depressive symptoms (hazard ratio [HR] = 
2.73; p = .01). 
 Lehto et al. (2000) set out to study the prevalence of depression at least 6 months 
following a CHD event. These events could include MI, bypass grafting, coronary angioplasty, 
and myocardial ischemia without infarction. The study was titled The EUROASPIRE Study 
(European Action on Secondary Prevention through Intervention to Reduce Events). This was a 
multi-center study conducted in nine European countries. The subjects consisted of 414 patients 
(284 males and 130 females) who were younger than 71 years (mean age for men was 60.9 years 
and for women was 63.6 years). These subjects were interviewed and examined and had their 
medical charts reviewed.  The NYHA Class was also assessed. Among these four diagnostic 
categories, one-sixth (14-19%) of the patients suffered from depression. The depression was 
highly associated with smoking (OR 1.7, 95% CI-1.2; 2.4) and poor NYHA class (OR 1.9, 95% 
CI 1.4; 2.6).  
 The Cardiovascular Health Study followed 5,888 subjects over 65 years of age that had 
no known current or prior cardiovascular disease (CVD). Four thousand four hundred and ninety-
three subjects were free of CVD at baseline as assessed by the CES-D. These 4,493 participants 
were followed for 6 years for the development of CVD and mortality. The cumulative mean 
depression score was assessed for each participant up to the time of a cardiac event (maximum 6 
year follow up). With every five-unit increase in mean depression score for the development of 
CVD was 1.15 (p = .006); the ratio for all cause mortality was 1.29 (p = < .0001). Among 
participants with the highest cumulative mean depression scores, the risk of CVD increased by 
40% and the risk of death increased by 60% compared with those who had the lowest mean 
scores (Ariyo et al., 2000).  
 Lauzon et al. (2003) conducted a study that involved five tertiary care and five 
community hospitals. These patients had been admitted for MI within two to three days of 
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admission. The patients were then recruited for the study by trained nurse interviewers. 
Information was collected from patient medical charts and from results obtained from the BDI. 
The BDI was administered and completed during the patients hospital stay and then mailed 
questionnaires were sent out at 30 days, 6 months, and 1 year after discharge. Of the 587 subjects, 
550 (94%) actually completed the BDI at baseline and of those 94%, 191 (35%) had a score of 10 
or more that would indicate at least mild depression. It was discovered that the rates of depression 
did not vary significantly over the follow-up period. These results were similar among patients 
that were admitted to tertiary care or community hospitals. 
 Krzyzkowiak (2007) conducted a study to assess depressive symptoms following an MI. 
Structured interviews including, Mini International Neuropsychiatric Interview, BDI, Social 
Readjustment Rating Scale, and Recent Life Changes Scale, were used in the analysis of 102 
patients hospitalized for MI. The findings showed that clinical (major) depression was diagnosed 
in 10.8% of these patients following an MI. However, depressive symptoms (> 10 points on the 
BDI) were detected in 40% of these patients. 
 The research seems to indicate that depression is generally quite widespread among 
cardiac patients following an MI (Frasure-Smith, 2000; Lehto et al., 2000). Murphy et al. (2008) 
found that individuals that began with high levels of either depression and/or anxiety, actually got 
worse over time. Kaptein et al. (2006) further went on to develop a system to identify different 
courses of depression following an MI with the last class identified (significant and increasing 
symptoms of depression), to have a statistically significantly higher risk for new cardiovascular 
events.  
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Following Hospitalization for CABG 
 Depression following CABG surgery is common. Depression has been found to predict 
slower recovery, increased prevalence of further depressive symptoms, and increased risk for 
developing further cardiac events (Pedersen et al., 2008). 
 At Duke University, 817 patients were about to undergo CABG surgery between May 
1989 and May 2001. Patients completed the CES-D scale prior to surgery, 6 months following 
surgery, and then were followed up on for a maximum of 12 years. Of these 817 patients, there 
were 122 deaths (15%) in a mean follow up of 5.2 years. Three hundred and ten patients (38%) 
met the criterion for depression (CES-D = 16), 213 (26%) for mild depression (CES-D = 16-26), 
and 97 (12%) for moderate to severe depression (CES-D = 27). When controlling for age, sex, 
number of grafts, diabetes, smoking, and left ventricular ejection fraction, survival analysis 
showed that patients with moderate to severe depression at baseline (adjusted HR 2.4, CI 1.4-4.0); 
p = .001) and mild or moderate to severe depression that persisted from baseline to 6 months 
(adjusted HR 2.2, (1.2-4.2); p = .015) had higher rates of death than did those with no depression 
(Blumenthal et al., 2003).  
 Connerney, Shapiro, McLaughlin, Bagiella, and Sloan (2001) assessed the effects of 
depression on specific outcomes following coronary artery bypass graft (CABG) surgery. Just 
prior to discharge, depression was assessed using a structured psychiatric interview and a 
questionnaire, the BDI. During the first year after surgery, 201 men and 102 women were 
followed. Out of the 303 patients surveyed, 63 patients (20%) met the modified diagnostic 
statistical manual IV criteria for MDD.  
 Rafanelli, Roncuzzi, and Milaneschi (2006) conducted a study to assess clinical and 
subclinical distress in a sample of patients who had undergone CABG surgery at 1 month and 
then at a 6-8 year follow up. Although the main findings of the study addressed the relationship 
between psychological variables and coronary events, it was discovered that of the 47 patients 
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that were interviewed using both the Diagnostic and Statistical Manual (DSM) and the new 
Diagnostic Criteria for Psychosomatic Research (DCPR), 36% of these patients were given a 
psychiatric diagnosis, and practically half of the sample met the criteria for a DCPR cluster. 
 What seems to be of even more interest is the connection that appears to exist between 
depression after CABG surgery and gender. It appears as though women tend to fare less 
favorably after CABG surgery, and a great deal of research exists to support such claims 
(Mitchell et al., 2005). 
 Burker et al. (1995) conducted a longitudinal study in order to determine the prevalence 
of depression in male and female patients about to undergo cardiac surgery. The study also 
examined what factors were associated with depression before and after surgery. One day before 
surgery (T1), and one day before hospital discharge (T2), 141 patients completed a battery of 
psychometric tests. These tests included the CES-D, the State-Trait Anxiety Inventory (STAI), 
and the Perceived Social Support Scale (PSSS). Data were also collected on 13 different 
physiological measures. Of these patients, 47% were considered to be depressed as defined by a 
score of 16 or above on the CES-D at T1. Interestingly, scores increased significantly from T1 (M 
= 15) to T2 (M = 20), with 61% of patients classified as depressed at T2. The factors associated 
with depression at T1 were female gender, higher state anxiety, and less social support. The 
patients depressed at T2 were characterized by higher scores on the STAI at T2 and higher scores 
on the CES-D at T1.  
 Vaccarino et al. (2003) conducted a study to explore whether female gender was 
associated with poorer outcomes following CABG surgery. The first 4 to 8 weeks following 
CABG surgery are generally the most vulnerable of the entire recovery period. This study 
followed 1,113 patients (804 men and 309 women) undergoing their first CABG between 
February 1999 and February 2001. Patients were interviewed at baseline, pre surgery, and 
between 6 to 8 weeks post surgery. The clinical data were extracted from medical records. The 
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findings showed that compared to men, women tended to be older and more often had unstable 
angina and CHF, lower physical function (PF), and greater depressive symptoms pre surgery. At 
6 to 8 weeks following CABG surgery, following adjustment for baseline characteristics, the rate 
of hospital readmission was 20.5% in women and 11.0% in men (p = .005). The mean number of 
physical symptoms and side effects was 2.5 in women and 2 in men (p = .0009). The PF remained 
unchanged in men (an increase in score of 0.3 points, 95% CI, -1.1-1.9), and depressive 
symptoms improved (a decrease of 0.2 depressive symptoms, 95% CI, -0.4- -0.04). Women 
showed, on average, a 13-point decline in PF (95% CI, -15.8 - -10.4), and an increase of 0.5 in 
depressive symptoms (95% CI, 0.1-0.9). It seems that women have a more difficult recovery 
compared to men, which is not explained by illness severity, pre-surgery health status, or other 
patient characteristics. 
 Mitchell et al. (2005) did conduct some research that disputed the above results, however. 
Setting out to test the hypothesis that women fare worse than men after CABG surgery, this study 
revisited the sex differences in depression during recovery after this surgery. The study followed 
137 patients (72 men and 65 women) that were about to undergo an elective first CABG surgery 
between July 2003 and April 2004. An interview was conducted < = 28 days before surgery and 
then again somewhere between 6 and 12 weeks following surgery, utilizing a structured 
diagnostic interview, by a clinician, for MDD and the BDI. The data were retrieved from patient 
charts. In both groups, the prevalence of MDD was 28.2%, possibly due to the stress of preparing 
for the surgery, but this number decreased to 16.4% after surgery (p = .038). In comparison, 
women had significantly more depression than men pre-CABG, with a mean BDI of 12.5 (95% 
CI, 10.6-14.4) versus 8.0 (95% CI, 6.3-9.8) for men (p = .0001), but not post surgery. 
Interestingly, there was a significant sex-by-time interaction with depressive symptoms in women 
that showed an almost 6-fold improvement greater than in men. The BDI change scores were 4.1 
(95% CI, 2.0- 6.1) for women versus 0.7 (95% CI, 1.0-2.5) for men (p = .008). The interaction 
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even remained significant after adjusting for such baseline characteristics as education, social 
support, and operative risk. This study shows that women benefited from CABG as much or even 
more than men in terms of their mental health. 
 A great deal of research points in the direction of increased depression following CABG 
surgery (Connerney et al., 2001; Rafanelli et al., 2006). There is also a trend in the research that 
points toward gender playing a part in the recovery following CABG (Vaccarino et al., 2003). 
Mitchell et al. (2005) disputes this claim as far as long-term outcome is concerned, but does 
report that women initially (pre surgery), do have higher levels of depression than men. The 
findings do suggest that there is something to the notion of gender and recovery from CABG. 
Following Hospitalization for CHF  
  Depression is common in CHF patients and is associated with poor QOL. Much research 
has been devoted to understanding how NYHA Class affects depressive symptoms in these 
patients (Freedland et al., 2003; Moser et al., 2005; Scherer et al., 2007). Furthermore, NYHA 
Class is one of the greatest predictors toward developing depression in patients who have CHF 
(Gott et al., 2006).  
 Moser et al. (2005) conducted a study to look at the multiple risk factors that increased 
rehospitalizations for patients being discharged with heart failure. Two hundred and two patients 
were evaluated for the following potentially modifiable risk factors: functional status, if patient 
lived alone, presence of depression, anxiety, poor QOL, symptom status and adherence to 
prescribed medications, symptom monitoring, and low-sodium diet. A good portion of these 
patients were severely functionally impaired (70% NYHA class III/IV). Of these particular 
patients, 69% of them were depressed. 
 Scherer et al. (2007) conducted a study to analyze depression and/or anxiety in primary 
care patients that had heart failure and also tried to identify protective factors to help resolve these 
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psychosocial distresses. The study was a longitudinal observation study in primary care practices 
in lower Saxony, Germany (n = 291). Depression and anxiety was assessed using the Hospital 
Anxiety and Depression Scale (HADS). Severity of heart failure was assessed using the NYHA 
classification system. The results showed that 26 (32.5%) of those patients that were distressed at 
baseline had a normal HADS score 9 months later. The rest of these patients remained distressed. 
Using logistic regression, baseline distress (OR 5.51%; 95% CI = 2.56 - 11.62), emotional 
problems (OR 1.08; 95% CI = 1.00 - 1.17), social support (OR 0.54; 95% CI = .35 - .83), and 
NYHA classification (OR 1.70; 95% CI = 1.05 - 2.77) independently predicted distress at follow 
up. High social support aided in the resolution of depression and anxiety and partnership and low 
levels of emotional problems protected patients that had started the study in a good emotional 
state. This study suggests that high NYHA class and emotional problems may contribute to 
depression and anxiety. 
 Freedland et al. (2003) conducted a study to report the prevalence of depression in 682 
hospitalized heart failure patients. The study also identified demographic, psychosocial, medical, 
and methodological factors that might affect prevalence. A modified version of the DSM-IV was 
administered to these patients to identify major and minor depression. Six hundred and thirteen of 
these patients also completed the BDI. The medical, demographic, and social data were obtained 
through hospital chart review, patient interview, and echocardiography. In this particular sample, 
20% of the patients met DSM-IV criteria for current MDD, and 51% scored higher than the cutoff 
for depression using the BDI (> or = 10). Interestingly, the prevalence of MDD differed 
significantly between the functional severity of the heart failure (NYHA Class), gender, age, 
employment status, past history of MDD, and dependence in activities of daily living (ADL). The 
prevalence of depression ranged from as low as 8% in patients that had a NYHA class of I, to as 
high as 40% in patients that had NYHA class of IV.  
 Pihl et al. (2005) wanted to determine if older patients suffering with heart failure and 
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their spouses experienced similar levels of depression. Data were collected from 47 couples. The 
Zung Self-rating Depression Scale (SDS) and the Short Form 36 (SF-36) were used. The results 
showed that patients suffering from heart failure and their spouses did not differ significantly in 
their mental health. Physical symptoms primarily dominated the experience of the depressive 
experience of the patient, which, in turn, affected the spouse accordingly. The patient’s 
depression was positively related to NYHA Class, while the spouse’s depression was related 
more with the higher age of the patient. 
 Jiang et al. (2001) conducted a study to determine the prevalence of depression in  
hospitalized CHF patients that were in the NYHA Class II or greater. The patients were all 18 
years of age and older, had an ejection fraction of 35% or less, and were admitted between March 
1, 1997 and June 30, 1998 to a cardiac care unit. Patients were given the BDI to assess 
depression. If a patient scored 10 or greater, they underwent a modified National Institute of 
Mental Health Diagnostic Interview Schedule to assess for MDD. All cause mortality and 
readmission rates were assessed. Of 374 patients screened, 35.3% had a BDI score of 10 or 
greater, and 13.9% had MDD.  
 Gott et al. (2006) studied the factors predictive of QOL amongst older people that had 
heart failure. Five hundred and forty two patients aged > 60 years with heart failure were 
recruited from community general practice surgeries. Patients completed a postal questionnaire 
that included disease-specific questions (Kansas City Cardiomyopathy Questionnaire), a generic 
QOL questionnaire (SF-36), and provided sociodemographic information. A multiple linear 
regression analysis identified the following factors as predictors of decreased QOL: NYHA 
functional class III or IV, evidence of depression, female, lower socioeconomic group, and two or 
more medical comorbidities. 
 Westlake et al. (2005) conducted a study to describe the prevalence of depression in 
patients with heart failure and the differences between patients with minimal versus mild to 
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severe depression. The data were collected from 200 patients having symptoms of heart failure 
that resulted from systolic dysfunction. These patients were, on average, 57.0 (+/- 12.1) years old, 
male 168 (84%), and in the NYHA functional class II or III (n = 140, 70.0%), with a mean 
ejection fraction (EF) of 25.5 +/- 6.4%. Minimal depression was described by 105 (52.5%) 
patients, mild depression was described by 62 (31%) patients, moderate depression was described 
by 30 (15%) patients, and severe depression was described by 3 (1.5%) patients. The significant 
differences between patients with minimal depression compared to mild to severe depression, 
were NYHA class (chi2 = 14.05, p = .003), maximal oxygen uptake (t = 2.62, p = .010), 6 minute 
walk distance (t = 4.22, p < .001), beta-blocker therapy (chi2 = 15.21, p < .001), perceived control 
(t = 7.93, p < .001), and neuroticism (t = -8.85, p < .001). 
 The research seems to show that depression is extremely common in the patient with 
CHF (Freedland et al., 2003; Jiang et al., 2001; Moser et al., 2005). NYHA Class (I-IV) 
independently predicted distress at follow up after hospitalization (Sherer et al., 2007), and had 
the greatest bearing on developing depression for those with CHF (Gott et al., 2006). 
The Effects of Untreated Depression 
 Major depression is a debilitating comorbid disorder that can seriously complicate 
recovery and increases the risks of further cardiac morbidity and mortality (Carney et al., 1996). 
Depression has been associated with a worse prognosis and increased coronary events after MI 
whether depression was evident before the cardiac event or diagnosed after the cardiac event 
(Kemp et al., 2003). The more severe the depression is, the greater the risk of death following a 
cardiac event (Kemp et al., 2003). A great deal of research has been conducted to show the 
connection between depression and the increased risk of morbidity and mortality following a 
cardiac event. Nonadherence to a physician’s medication treatment plan is increasingly 
recognized and can cause adverse cardiac outcomes (Gehi, Ali, Na, & Whooley, 2007). This 
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section will address the effects of untreated depression that include: increased risk of a coronary 
event, decreased feelings of wellbeing and QOL, decreased medication compliance, and 
decreased risk factor modification.  
Increased Risk of a Coronary Event 
 Barefoot and Schroll (1996) conducted a study spanning 27 years from 1964-1991 in 
Glostrup, Denmark. The study included 409 men and 321 women participants. Physical and 
psychological exams established each patient’s baseline risk factor and disease status, and their 
level of depressive symptomatology. Initial MI was observed in 122 participants, and 290 deaths 
occurred during follow up, ending in 1991. A two standard deviation (SD) difference in 
depression score was associated with a relative risk of 1.71 (p = .005) for MI and 1.59 (p = .001) 
for deaths from all causes. These findings remain unchanged even after controlling for individual 
risk factors and sign of disease at baseline. This study concluded that high levels of depressive 
symptoms increase the risk of MI and mortality. The research suggests that depression is best 
viewed as a continuous variable that represents a chronic psychological characteristic rather than 
a discrete, episodic psychiatric condition. They found that depression associated with ischemic 
heart disease increased morbidity for both men and women with a 70% higher risk for re-
infarction and a 60% higher mortality rate.  
  Parakh et al. (2008) was interested to see if the effects of depression on mortality in the 
short term following an MI could be persistent in the long term. The study tried to determine 
whether depression during hospitalization for MI, which could predict mortality at 4 months, 
could also predict mortality 8 years later. The study was prospective and observational and 
included 284 hospitalized patients with MI. Major depression and dysthymia were assessed using 
the Diagnostic and Statistical Manual of Mental Disorders, revised third edition. Depressive 
symptoms were assessed using the BDI. Mortality was determined by using the Social Security 
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Death Index. Any depression (major, dysthymia, and/or BDI score of  > 10, was detected in 76 
patients (26.8%). The 8 year mortality rate was 47.9% (136 deaths). Any depression at the time of 
the MI was not associated with mortality at 8 years in an adjusted hazard ratio (HR 1.25, 95% CI, 
0.87-1.81, p = .22).   
 Ariyo et al. (2000) went on further to investigate if depressive symptoms were a risk for 
CHD and mortality in an apparently healthy elderly sample. The study was prospective and 
included 5,888 elderly Americans that were enrolled in the Cardiovascular Health Study. Of these 
5,888 participants, 4,493 were free of cardiovascular disease at baseline. The depression-free 
participants provided annual information regarding their depressive status as assessed by the 
CES-D.  For 6 years, these participants were followed for the development of CHD and mortality. 
A cumulative mean depression score was assessed for each participant up until the time of a 
cardiac event. Using time-dependent, proportional-hazards models, the unadjusted hazard ratio 
that is associated with every five-unit increase in mean depression score for the development of 
CHD was 1.15 (P = .006). Of the participants that had the highest cumulative mean depression 
scores, the risk of CHD increased by 40% and the risk of death by 60% compared with those who 
had the lowest mean scores. 
Decreased Medication Compliance  
 Medication compliance is a common problem in cardiovascular patients with depression 
(Goldstein, 2006; Lesperance & Frasure-Smith, 2000). Carney et al. (1996) conducted a study 
that showed that 69% of nondepressed subjects were adherent to their medication treatment plan, 
whereas only 45 % of the depressed group was compliant. 
 Gehi, Haas, Pipkin, and Whooley (2005) conducted a study to examine the association 
between current major depression, assessed by using the Diagnostic Interview Schedule, and self-
reported medication adherence. The study was cross sectional and included 940 outpatients with 
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stable CHD. Of the participants, 204 (22%) had major depression. Of the 204 depressed patients, 
28 (14%), reported not taking their medications as prescribed whereas 40 (5%) of 736 
nondepressed patients reported the same (OR 2.8, 95% CI, 1.7-4.7; p < .001). Two times as many 
depressed patients as nondepressed patients (18% vs. 9%) reported that they forgot to take their 
medications (OR, 2.4; 95% CI, 1.6-3.8; p = .001). When asked about deciding to skip taking their 
medications, 9% of depressed and 4% of nondepressed reported doing so (OR, 2.2; 95% CI, 1.2-
4.2; p = .01). This relationship between depression and nonadherence continued to persist even 
after adjusting for certain confounding variables like age, ethnicity, education, social support, and 
cardiac disease severity (OR, 2.2; 95% CI, 1.2-3.9; p = .009). This study appears to show an 
association between depression and medication nonadherence. Medication nonadherence may 
likely contribute to unfavorable cardiovascular outcomes.  
 Gehi et al. (2007) conducted a study to evaluate the risk of cardiovascular events 
associated with medication nonadherence. The participants were 1,015 outpatients with already 
established CHD. A single question was asked, “In the past month, how often did you take your 
medications as the doctor prescribed?” The nonadherence rate was defined as not taking 
prescribed medications 75% of the time or less. Of the 1,015 participants, 83 (8.2%) reported 
nonadherence to their medications, and 146 (14.4%) developed cardiovascular events. 
Furthermore, the self reported nonadherent patients were more likely then the adherent patients to 
develop subsequent cardiac events during 3.9 years of follow up (22.9% vs. 13.8%, p = .03). 
Decreased Feelings of Well-being/QOL 
 Depression has been shown to lead to decreased feelings of overall well-being, or QOL 
(Feinstein et al., 2006; Hermann-Lingen, 2001). Participants with depressive symptoms are more 
likely to report mildly diminished QOL (Ruo et al., 2003). 
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 Ruo et al. (2003) conducted a study that measured and compared the contributions of 
depressive symptoms to cardiac function, and health status of patients that had coronary artery 
disease. A cross-sectional study was conducted with 1,024 participants in the San Francisco Bay 
area from September 2000 to December 2002. QOL was one variable that was measured using 
the Seattle Angina Questionnaire. The results showed that of the 1,024 participants, 201 (20%) of 
these participants had depressive symptoms. Furthermore, participants with depressive symptoms 
were more likely to report mildly diminished QOL (67% vs. 31%; p < .001). 
 Pedersen and Denollet (2004) conducted a study that focused on Type D personality. The 
study focused on whether patients with Type D personality were at increased risk for 
cardiovascular morbidity and mortality (OR ranging from 4.1-8.9, p < 0.0001) independent of 
standard cardiac risk factors. These patients were also found to suffer from impaired QOL. 
 Heo et al. (2007) conducted a study to determine if there were gender differences in the 
effects of physical and emotional symptoms as they related to HRQOL. The subjects consisted of 
51 men and 47 women with heart failure. The data were analyzed using regression analyses. No 
gender differences existed in physical or emotional symptom status, but there were differences in 
the dynamic relationships among the variables. In women, however, physical symptoms were 
related to HRQOL (r(2) = .27 p < .001,). In men, depression affected HRQOL (r(2) = .40 p < 
.001). The results showed gender differences in the dynamic relationships among variables 
related to HRQOL. 
 The connection seems to exist that would suggest that if patients suffer from depressive 
symptoms, they are more likely to report decreased QOL (Ruo et al., 2003). 
Physician Under Detection of Depression 
 A diagnosis of depression is missed in 50% of all cases. Of those 50%, less than 10% of 
these cases have any kind of treatment instituted (Thornton, 2001). Amin et al. (2006) found that 
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hospitalized patients with moderate to severe depressive symptoms by PHQ were only recognized 
24.5% of the time as evidenced by documentation in the patient chart. Despite its clinical 
importance and high remission rate, depression still goes under recognized and under treated in 
cardiac patients (Hermann-Lingen, 2001). 
 In a national survey, 796 cardiovascular physicians were polled and were found to be 
aware of the importance of depression in cardiovascular disease. This was evidenced by the fact 
that 84.8% of surveyed physicians believed that up to half of their patients with CHD have 
depression (Feinstein et al., 2006). Further questioning revealed that 71% of these physicians 
asked less than half of their patients with CHD about depression and 79% used no standard 
screening methods. Interestingly, only 55% of these physicians felt comfortable making a 
diagnosis of depression.  
 Several explanations have been identified to explain why physicians are missing the 
diagnosis of depression in their cardiac patients. Discriminating symptoms of depression from 
those related to other medical conditions, or comorbidities, can be difficult (Davies, Jackson, 
Potokar, & Nutt, 2004; Davies et al., 2004). Comorbidities not only make diagnosis difficult, but 
they also increase a patient’s resistance to treatment (Rosenthal, 2003). Magruder-Habib et al. 
(1990) found that the prevalence and severity of a patient’s comorbidities can also complicate 
diagnosis. They conducted a study at a medical clinic at a VA medical center in Durham, North 
Carolina. Eighth hundred and eighty male veterans were followed longitudinally by six board 
certified internists. These participants were screened for depression using three specific screening 
tools: (a) Diagnostic and Statistical Manual-III, (b) Self-Rating Depression Scale (SDS), and (c) 
Diagnostic Interview Schedule. Those patients who screened positive on at least two screenings, 
were randomly assigned to one of two groups: Group A, primary physician informed of screening 
results; or Group B, primary physician not informed of screening results. Physicians were blinded 
to the study hypothesis. One hundred patients met both screening criteria (12.7%). The results of 
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the study showed that feedback to physicians of screening tool scores of previously unrecognized 
depressed patients makes a significant difference in greater recognition (56.2% vs. 34.6%). This 
is especially true regarding patients with high somatic (p < .05) or low psychologic symptoms of 
depression (p < .05). 
 One possible explanation is that pain and depression share the same neurologic pathway 
(Trivedi, 2004). Somatic symptoms such as joint pain, limb pain, back pain, gastrointestinal 
problems, fatigue, psychomotor activity changes, appetite changes, diminished energy, and sleep 
disturbances, can overlap with those of medical illnesses (Goldstein, 2006; Trivedi, 2004). 
Somatic symptoms may be the only way some groups of people know how to express the 
presence of an emotional problem, especially if depression carries a cultural or group stigma. This 
is especially true in seniors, who may not know any other way to express these feelings 
(Rosenthal, 2003). In a general sense, the worse the physical pain and symptoms, the more severe 
the depression is (Trivedi, 2004). 
    Another potential barrier to recognition of depression in cardiac patients is the 
physician’s preconceived notion that depressive symptoms may reflect a “reaction” to their 
cardiac event (Amin et al., 2005). It can oftentimes be difficult to distinguish transient 
psychological symptoms from those that represent major depressive illness (Davies et al., 2004). 
 Other reasons for low rates of detection include: characteristics of the patient, physician 
knowledge of depression, physician skill in recognizing and treating depression, a physicians 
negative attitude toward mentally ill patients, the quality and precision of diagnostic information 
available, and the time constraints imposed by managed care (Magruder-Habib et al., 1990; 
Rosenthal, 2003). 
 Physicians and patients need to become more aware of the broad spectrum of depressive 
symptoms in order to evaluate and treat depression more effectively (Trivedi, 2004). The 
diagnosis of depression depends on systematic patient evaluation by experienced clinicians 
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trained in the recognition of these disorders (Januzzi & Pasternak, 2002). Physicians also must 
learn to delegate information gathering to trained personnel, in the form of questionnaires and 
rating scales. This will allow the physician to assess the collected data and then focus on 
diagnostic issues (Rosenthal, 2003).  
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   CHAPTER III 
METHODOLOGY 
 This chapter provides an overview of the completed study, by reviewing (a) the research 
design, (b) sample, (c) instrumentation, (d) pilot testing, (e) statistical analyses used, and (f) data 
collection procedures. 
Research Design 
 A one-group, cross sectional, research design was employed to measure the severity of 
depression in hospitalized cardiac patients. The data were gathered utilizing the PHQ-9, a self-
report depression inventory (see Appendix A).  
Sample 
Selection Criteria 
 Utilizing convenience sampling, all patients who were admitted as inpatients in the 
critical care unit of a hospital in the intermountain west, who had a troponin blood test ordered, 
CABG, aortic valve replacement (AVR), mitral valve replacement, percutaneous transluminal 
coronary angioplasty (PTCA), stent, CHF, atrial fibrillation, unstable angina, ACS, pacemaker 
implantation, MI, or chest pain, were considered for inclusion in this study. Patients were 
excluded if they had altered levels of consciousness (n = 5), deceased before hospital discharge, 
were under the care of hospice, or were non-English speaking (n = 21).  
 This researcher approached and introduced herself to patients during their hospitalization 
that met the study criteria. The content of the study was explained and patient was asked if he/she 
would like to participate. If the patient agreed to participate, then informed consent was obtained 
(see Appendix B). The patient was then instructed on how to fill out the PHQ-9. While the patient 
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completed the PHQ-9, the researcher was available at the nurse’s station to answer any questions. 
Upon completion, the PHQ-9 was collected by the researcher and taken to a locked security file 
cabinet. 
Sample Size 
 The sample size necessary for this study was determined by a power analysis conducted a 
priori under the guidance of the Office of Methodological and Data Sciences at Utah State 
University. The analysis was based upon an established alpha level = .05, an estimated power of 
0.8 and a Cohens  of 0.5. The alpha was chosen due to the general acceptance among researchers 
and professionals that p = .05 is a reliable indicator that a relationship between variables is 
statistically significant (Cohen, 2001). The δ 0.5 is considered moderate in evaluating 
relationships between variables and was thus chosen to be appropriate for this study. Using 
moderate power in determining the sample size also balances the risk of making Type I or Type II 
errors (Cohen, 2001). The sample size that was determined to be adequate for this study was 110. 
Sample Characteristics 
Table 2 presents the demographic information for this study’s participants. One hundred 
and eleven patients participated in the study-61 were male and 50 were female.  The patients 
ranged in age from 22 to 95-years old. The diagnoses that were included in the study were chest 
pain, CHF, atrial fibrillation, pacemaker implants, MI, ACS, and rule out MI. The marital status 
categories used were married (n = 76), single (n = 5), widowed (n = 20), and divorced (n = 8).  
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Table 2 
Demographic Characteristics of the Sample 
Characteristics n Percent 
Age (categories) 
          0-44 years 
          45-60 years 
          61-70 years 
          71-80 years 
          81 or greater 
 
5 
22 
14 
37 
33 
 
4.5 
19.8 
12.6 
33.3 
29.7 
Gender 
          Male 
          Female  
 
61 
50 
 
54.9 
45.0 
Diagnosis 
          Chest pain 
           CHF 
           A. Fib 
           Pacemaker 
           MI 
           ACS 
           Rule out MI 
 
37 
20 
27 
9 
7 
7 
4 
 
33.0 
18.0 
24.3 
8.1 
6.3 
6.3 
3.6 
Marital status 
           Married 
           Single 
           Widowed 
             Divorced 
 
76 
5 
20 
8 
 
68.5 
5.4 
18.0 
8.1 
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Instrumentation 
 The instrument selected to identify cardiac patients with depressive symptoms in this 
study is called the PHQ-9 (see Appendix A). This instrument was developed by Robert L. Spitzer, 
M.D., Janet B.W. Williams, M.D., and Kurt Kroenke, M.D., and is publically available online. 
The PHQ-9 is designed to facilitate the recognition and diagnosis of one of the most common 
mental disorders in primary care patients (i.e., depression). This instrument carries the added 
property to identify the severity of the depression for patients with a depressive disorder. A PHQ 
Depression Severity Index score can be calculated and repeated over time to monitor change. The 
brevity of this instrument makes it a useful clinical and research tool. The instrument consists of 
nine items aimed at assessing severity of depression by having participants indicate the frequency 
of their symptoms with a range of responses: not at all = 0, several days = 1, more than half the 
days = 2, and nearly every day = 3. A check is made by the appropriate level 0, 1, 2, or 3, for each 
question. The point value for each check is added up to give a total score. A score of 5-9 indicates 
mild depression, a score of 10-14 indicates moderate depression, a score of 15-19 indicates 
moderately severe depression, and a score of 20-27 indicates severe depression. Any patient 
scoring > 5 was classified as depressed for the purposes of this study (Banazak, 2000). 
 The PHQ-9 has been validated and found to have concurrent validity with the BDI (r = 
.67, p < .001). It also has been found to have had 1 month test-retest reliability (r = .894, p < 
.001) and an internal consistency of items at 0.85 (Adewuya, Ola, & Afolabi, 2006). Using the 
receiver operating characteristic (ROC) curve, the optimal cut-off score for minor depressive 
disorder is 5 with a sensitivity of 0.897, specificity of 0.989, a positive predictive value of 0.875, 
a negative predictive value of 0.981, and overall correct classification rate of 0.973. MDD is 10 
with a sensitivity of 0.846, a specificity of 0.994, a positive predictive value of 0.750, a negative 
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predictive value of 0.996, and OCC rate of 0.992 (Adewuya et al., 2006). Any patient scoring > 5 
was classified as depressed for the purposes of this study. 
 Kroenke, Spitzer, and Williams, (2001), conducted the PHQ Primary Care Study that was 
conducted from May 1997 to November 1998 to assess the reliability, efficiency, criterion 
validity, and construct validity of the PHQ-9. Three thousand patients presenting to five general 
internal medicine clinics and three family practice clinics participated in the study. Before seeing 
the physicians, the patients completed the PHQ-9. These same patients additionally completed the 
Medical Outcomes Study Short-Form General Health History (SF-20). The SF-20 measures 
functional status in six domains (all scores from 0 to 100; 100 = best health). Patients also 
estimated the number of physician visits and disability days during the past 3 months. Midway 
through the PHQ Primary Care Study, a Mental Health Professional (MHP) (a PhD clinical 
psychologist or one of three senior psychiatric social workers) attempted a phone interview with 
all entered subjects who agreed to participate within 48 hours of completing the PHQ-9. 
Agreement between the PHQ-9 and the MHP diagnosis was examined. The sensitivity was 73% 
and maintained a high specificity of 94%. The internal reliability of the PHQ-9 was calculated 
with a Cronbach’s alpha of 0.89. The correlation between the PHQ-9 that the patient completed in 
the clinic and that administered over the telephone by the MHP within 48 hours was 0.84. The 
mean sores were nearly identical (5.08 vs. 5.03). As PHQ-9 scores increased, worsening 
functional ability ensued. Permission to use this instrument has been granted by Kurt Kroenke as 
this instrument is free for the public to use. 
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Pilot Testing 
 The purpose of the pilot study was to discover limitations of the survey such as: 
understandability of the survey questions, time needed to complete the survey, and even 
limitations of the questions. The pilot study took place at an outpatient cardiac rehabilitation 
program located in a hospital in the intermountain west. Cardiac patients engaging in the 
outpatient cardiac rehabilitation program were asked to complete the PHQ-9 once informed 
consent had been obtained. Upon completion of the PHQ-9, the patients were asked to provide 
feedback regarding the questionnaire and it’s utility. A separate form (see Appendix C) was 
included with the PHQ-9 for each patient to complete to provide input about the questionnaire. 
This form had specific questions that were answered using a Likert scale. A comments section 
was also provided to obtain additional input not falling within these specific questions. The time 
necessary to complete the survey was determined from the pilot study and was approximately 10 
minutes. The comments and input gained from the pilot study helped to direct the process in the 
actual study that was conducted on hospitalized cardiac patients. 
 Particular findings from the pilot study helped the researcher to modify the final study. 
The majority of patients participating in the pilot study felt that the PHQ-9 was easy to read and 
follow. It was discovered that patients required verbal reinforcement of the written instructions in 
order to be clear as to how to select the most appropriate answer for the items on the PHQ-9. In 
the actual study, this researcher did this with each participant.  
Data Collection 
  This researcher screened patients admitted as inpatients to one critical care unit in the 
intermountain west in accordance with Utah State University Institutional Review Board (IRB) 
guidelines and hospital policies that have already been approved by the hospital research review 
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board (see Appendix E). Evidence of cardiac patient status was determined through a daily 
review of a computerized list of all inpatients admitted to the facility having had a troponin blood 
test ordered. This test is given to any patient who is suspected of having an ACS. This researcher, 
administered the PHQ-9 to cardiac patients who have had CABG, mitral valve replacement 
(MVR), aortic valve replacement (AVR) surgery, a percutaneous transluminal coronary 
angioplasty (PTCA), stent placement, atrial fibrillation, CHF, unstable angina, ACS, MI, 
pacemaker implantation, and chest pain, and who have come to a stable point following their 
hospitalization. 
 This researcher determined if the patient met study inclusion criteria and if the patient’s 
physician had agreed to allow the researcher to administer the PHQ-9. These physician 
permission forms were collected previously (see Appendix D). A list of these physicians was with 
the researcher when determining whether patients would be included in the study. The student 
researcher introduced herself to each patient and explained that she would like the patient to be a 
participant in a study on “Depression Detection in Hospitalized Cardiac Patients.” Once the 
patient agreed to participate, informed consent was obtained. The patient was then instructed on 
how to complete the PHQ-9 and told that it should take approximately ten minutes to complete. 
Upon completion of the PHQ-9, the student researcher took the survey and delivered it to the 
designated research depository that had a locked file cabinet in the researcher’s office. 
 This researcher then audited all charts of patients that scored > 5 on the PHQ-9 following 
the patient’s discharge from the hospital.  This was done in order to be able to view all 
documentation in the completed chart. Patient charts were audited in order to assess the current 
practice habits for recognizing active depression in cardiac patients by their cardiac or internal 
medicine physician(s). Multiple methods were used to identify whether depressive symptoms 
were documented in the inpatient hospital chart. The methods included: (a) a diagnosis of 
depression in the patient chart, (b) a diagnosis of depression at the time of hospital discharge, (c) 
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evidence of active depression therapy (antidepressant medications started or dose adjusted of 
current medication, psychological counseling, or psychiatric consultation), and (d) evidence that 
depressive symptoms would be followed or management would be instigated as an outpatient. 
 Low-dose tricyclic antidepressants are frequently used for insomnia, neuropathic pain, 
and fibromyalgia, and Buproprion is often used for smoking cessation. The charts of patients 
taking these medications were reviewed to identify whether these medications were prescribed for 
an indication other than depression. Patients whose only criterion for recognition was the use of 
these medications and whose charts indicated that these medications were prescribed for a non-
depressive disorder were classified as unrecognized. 
Data Analysis 
 The data from the questionnaires were entered into SPSS version 17.0 for analysis. 
Following data entry into the program, such data were randomly checked for accuracy regarding 
data entry. Statistical tests were run to answer the research questions (see Table 3). 
 The chi-square goodness of fit test was used to determine how well the obtained sample 
proportions fit the population proportions specified by the null hypothesis on research questions 2 
and 4 (Gravetter & Wallnau, 2005). Logistic regression was used to answer research question 5 to  
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Table 3 
Research Questions and Data Analysis Procedures 
Research question Measure Data analysis 
1.  Are cardiologists and/or                                   
internal medicine physicians detecting 
depression in their cardiac patients during a 
hospitalization admission accurately as 
compared to the PHQ-9? 
Patient records  
PHQ-9 > 5 
Fisher’s Exact Test 
2.  Are there differences in the rates of 
depression in the different diagnostic groups? 
PHQ-9 > 5 Chi-Square 
Goodness of Fit Test 
3.  Are there differences between the rates of       
depression in male and female patients? 
PHQ-9 > 5 Fisher’s Exact Test 
4.  Are there differences between the rates of      
depression in patients who are married, single,    
widowed, or divorced? 
PHQ-9 > 5 Chi-Square 
Goodness of Fit Test 
5.  Does the age of a patient predict the risk for   
depression following a cardiac event? 
PHQ-9 > 5 Logistic Regression 
6.  Are there differences between the rates of       
depression in patients that have a prior cardiac 
diagnosis versus those with a new cardiac 
diagnosis? 
PHQ-9 > 5 Fisher’s Exact Test 
 
determine whether the age of participants predicted depression among those patients. The 
Fisher’s exact test was used to answer research question 1, 3, and 6 to determine whether 
proportions are significantly different from what is expected. 
Summary 
 This chapter discussed the methodology for this research study concerning depression 
detection in hospitalized cardiac patients. The topics that were covered were research design, 
sampling procedures, instrumentation, pilot study, data collection, and data analysis. 
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CHAPTER IV 
RESULTS 
 
 
 This study was carried out to expand the research that has already been conducted by 
assessing the rate of detection of depression among hospitalized patients diagnosed with a wide 
spectrum of cardiac-related disorders. This chapter discusses the results of the six research 
questions introduced in Chapter I and III. The student researcher used SPSS 17.0 software in all 
of the analyses. The results are presented below. 
Question Number One 
Research question #1: Are cardiologists and/or internal medicine physicians detecting 
depression in their cardiac patients during a hospital admission accurately as compared to the 
PHQ-9?  A total of 111 PHQ-9 surveys were administered to hospitalized patients with a 
suspected cardiac diagnosis. Eighty-three patients were identified as depressed and 28 patients 
were identified as nondepressed by the PHQ-9 (see Table 4). Of the 83 patients identified as 
depressed, only nine of those patients were identified as depressed by physicians as measured by 
their notes in the patients’ charts. Physicians identified two patients as depressed that were not 
identified by the PHQ-9. A comparison of the patients identified as depressed by the PHQ-9 
(83/111 = 75% depression rate) and those identified by physicians (11/111 = 10% depression 
rate) reveals different rates of detection. The fishers exact test revealed (p = .727, FET). The null 
hypothesis for the fishers exact test for independence states that the two variables being measured 
are not associated; that is, for each individual that the PHQ-9 identified depression, there is no 
association related to the physicians recognition of depression. 
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Table 4 
Patient Depression Detection 
 
  
PHQ-9 identified depression  
Total Yes        % No   %      
Physician-identified depression      Yes 
                                                          No 
  9       (11)  2   (7) 11 
100 74       (89) 26 (11) 
                                                       Total 83       (75) 28 (25)  111 
 
 
This further supports the observed lack of physician identification of depression in their patients.  
The sensitivity (i.e., true positive rate) for physician recognized depression is only 10.8% as noted 
by the PHQ-9.  
Question Number Two 
Research question #2: Are there differences between the rates of depression in the different 
diagnostic groups? Each of the 111 patients fell into one of seven cardiac diagnostic groups (see 
Table 5). The highest rates of depression were identified in the MI group (7/7 = 100%) and the 
R/O MI group (4/4 = 100%). The next highest rates of depression were identified in the CHF 
group (19/20= 95%) and the ACS group (5/7 = 71%). The lowest rates of depression were 
identified in the A Fib group (18/27 = 67%) and Pacer group (6/9 = 67%). Although rates of 
depression between diagnostic groups differed from one another, those differences were not 
statistically different from one another (chi-square = 11.271, p = .080). 
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Table 5 
Depression Among Diagnostic Groups 
    PHQ-9 identified depression  
Total Yes       % No % 
Cardiac diagnosis   CP 
CHF 
A. Fib 
Pacer 
MI 
ACS 
R/O MI 
24      
19      
18      
6       
7       
5       
4        
64.8  
95.0  
66.6  
66.6  
100.0  
71.4  
100.0 
13 
1 
9 
3 
0 
2 
0 
35.1 
5.0 
33.3 
33.3 
0 
28.5 
0 
37 
20 
27 
9 
7 
7 
4 
                                   Total 83    74.8 28 25.2 111 
 
Question Number Three 
Research question #3: Are there differences between the rates of depression in male and 
female patients? There were 61 males and 50 females that completed the PHQ-9. Of those 111 
surveys, there were 44 males and 39 females that were identified as depressed (see Table 6). A 
comparison of the male patients identified as depressed (44/61 = 72% depression rate) and female 
patients identified as depressed (39/50 = 78% depression rate) revealed similar rates of detection 
(p= .517, FET). 
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Table 6 
Male and Female Depression 
Gender Yes              %         No             % Total 
Male        44             (72.1)         17           (27.9) 61 
Female        39             (78.0)         11           (22.0) 50 
 
 
 
Question Number Four 
 
Research question #4: Are there differences between the rates of depression in patients 
who are married, single, widowed, or divorced? The highest rates of depression were identified 
in the divorced patients (8/9 = 89%), the widowed patients (17/20 = 85%) and the single patients 
(5/6 = 83%) (see Table 7).  The lowest rate of depression was found in the married patients  
 
Table 7 
Marital Status and Depression 
Marital status Yes % No        % Total 
Married 53 69.7 23        30.2 76 
Single 5 83.3 1         16.7 6 
Widowed 17 85.0 3         15.0 20 
Divorced 8 88.9 1         11.1 9 
Total 83 74.8 28        25.2 111 
 
(53/76 = 70%).  A chi-square goodness of fit test indicated that the rates of depression between 
marital status groups did not differ significantly (chi-square = 6.060, p = .109). 
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Question Number Five 
Research question #5: Does the age of the patient predict the risk for depression following a 
cardiac event? Logistic regression was used to answer this question. Age was used as a predictor 
variable and depression detection, as indicated on the PHQ-9, was used as the dependent variable 
in the model. The model accounted for 12% to 17% of the variance in depression detection. Table 
8 gives coefficients, the Wald statistic, associated degrees of freedom, and p-values for age. The 
table indicates that age does not reliably predict depression among the patients in this sample (p = 
.251). 
Table 8 
Variables in the Equation 
 B S.E. Wald df Sig. Exp(B) 
Age -0.017 0.015 1.316 1 0.251 0.983 
Constant 0.137 1.077 0.016 1 0.899 1.146 
 
Question Number Six 
Research question #6: Are there differences between the rates of depression in patients 
that had a prior cardiac history versus those with a new diagnosis? There were 66 patients with a 
prior cardiac diagnosis and 45 patients with a new cardiac diagnosis that completed the PHQ-9 
(see Table 9). There were 53 patients with a prior cardiac diagnosis identified as depressed and 30 
patients with a new cardiac diagnosis identified as depressed. A comparison of the patients with a 
prior cardiac diagnosis (53/66 = 80% depression rate) and patients with a new cardiac diagnosis 
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(30/45= 67% depression rate) revealed rates of detection that were not statistically significantly 
different (p= .328, FET).  
Table 9 
Prior and New Cardiac Diagnosis and Depression 
 PHQ-9 identified depression  
Total Yes % No     % 
Prior cardiac diagnosis  
Yes 
 
53   
 
80.3 
 
13  
 
19.7 
 
 66 
                                     No 30      66.6 15   33.3 45 
                                Total  83   74.8 28  25.2 111 
 
Summary 
 Chapter IV presented the results of the research questions posed in Chapters I and III.  
The next chapter will provide a discussion relating the results found in this study and a 
comparison to those found in past research. Suggestions for future research and the implications 
for the discipline of health education will also be explored. 
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CHAPTER V 
DISCUSSION 
Introduction 
The current study was intended to determine whether cardiologists and/or internal 
medicine physicians are identifying depression in their patients admitted to the intensive care unit 
with a cardiac diagnosis.  While past research has shown that physicians are not consistently 
identifying depression in their patients, these studies have been limited to very specific diagnostic 
groups (Amin et al., 2005; Feinstein et al., 2006; Hermann-Lingen, 2001; Simon et al., 2004; 
Thornton, 2002). Furthermore, a great deal of research exists that supports the notion that 
prolonged depression in the cardiac patient increases a patient’s risk for further cardiac events 
(Barefoot & Schroll, 1996; Carney et al., 1996; Gehi et al., 2005; Parahk et al., 2008).   This 
chapter will discuss the results of Chapter IV and the implications they may have for health 
educators.  Suggestions will also be presented for future researchers. 
Research Question Number One 
 Research question one was designed to determine whether those patients that scored > 5 
on the PHQ-9 were also being identified as depressed by the physician who was following their 
case during their hospital stay.  This study found large differences between the rates of depression 
identified by the PHQ-9 (75%) and the rates of depression identified by physicians (10%).  The 
fisher’s exact test revealed no association between these variables.  This further supports the idea 
that physicians are doing a poor job of identifying depression in their cardiac patients. 
 Prior research, however, has also indicated a gap.  Thornton (2001) found that depression 
was missed in 50% of all cases.  Of those 50%, less than 10% of these cases had any kind of 
treatment instituted.  Feinstein et al. (2006) reported that in a national survey of 796 
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cardiovascular physicians, 84.8%  believed that up to half of their patients with CHD had 
depression and yet 71% asked less than half of their patients with CHD about depression. 
 It could be argued that physicians are too busy to think about any medical problems other 
than those that they are there to directly diagnose and resolve.  As managed care becomes more 
prevalent in the United States, so do the restrictions that physicians face regarding time spent with 
the patient.  Documentation is becoming so cumbersome that many physicians may feel 
overwhelmed by the new rules and regulations that they must learn to implement from year to 
year.  This process, unfortunately, is constantly changing as reimbursement issues become more 
complex.  Cardiologists, it would seem, recognize the likely prevalence of depression among their 
patients, but don’t see it as a part of their role to screen for depression, even though depression 
has a negative effect on cardiovascular outcomes. Cardiologists may deem this responsibility as 
belonging to the patient’s primary care physician.   
 The disparity observed may just be a result of the difficulty in discriminating symptoms 
of depression from those related to other medical conditions, or co-morbidities (Davies et al., 
2004).  Somatic symptoms such as joint pain, limb pain, back pain, gastrointestinal pain, fatigue, 
psychomotor activity changes, appetite changes, diminished energy, and sleep disturbances, can 
be manifested by depression or by other medical illnesses (Goldstein, 2006; Trevidi, 2006).  It 
may seem less difficult and less time consuming to simply treat the somatic symptoms that a 
patient is experiencing.  Determining why a patient is depressed can be a complicated and time-
consuming process.  To get to the core of some problems may be far beyond the scope of care 
with which a physician is comfortable.  A physician may be afraid of the liability that he/she 
might face if a diagnosis of depression is given.  If a physician identifies depression, then 
wouldn’t it also be his/her responsibility to make sure that the patient be treated for this problem?  
From an ethical standpoint, a physician should feel it his responsibility to treat depression if 
discovered.  It would, therefore, be advantageous for a screening tool to be administered prior to a 
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patient meeting with the physician so that a depression score could then be communicated with 
the physician and the issue addressed.  The physician could then refer the patient to another 
provider in order to ensure that the patient received the help that he/she needs.  Unfortunately, 
somatic symptoms may be the only way that some populations express the presence of an 
emotional problem, especially if depression carries a cultural or group stigma (Rosenthal, 2003).  
 This study was conducted in a smaller U.S. city and therefore the hospital is considered 
to be a community hospital.  Physicians in a smaller community hospital setting may be more 
inclined to follow certain rules set by the powers that be.  Depending on what those rules are, the 
possibility of “stepping on the other guy’s toes” or “overstepping boundaries” is very real and 
may be a social moray that must be followed in order to be accepted or respected. 
 Therefore, it remains that physician detection of depression in cardiac patients is under 
represented.  The factors that appear to be causing this under representation are physician time 
restraints, documentation issues, guidelines and regulations, and possibly liability issues.  A 
physician’s tendency to treat a patient’s somatic symptoms first may also represent either their 
lack of experience or the hesitation to delve in to the realm of treating mental health issues. 
Research Question Number Two 
Research question number two asked: are there differences between the rates of 
depression in the different diagnostic groups?  The current study has MI and CHF included in its 
diagnostic groups and has added CP, A fib, Pacer, ACS, and R/O MI.  Of all of these diagnostic 
groups combined, it was found that the rates of depression range anywhere from 67-100%.  No 
statistically significant differences between groups were found.  Notably, the rates of depression 
identified in this study were higher than previous research which showed depression ranging from 
15-65%  (Amin et al., 2005; Feinstein et al., 2006; Hermann-Lingen, 2001; Kaptein et al., 2005), 
possibly because the PHQ-9 captures mild, moderate and severe depression when utilizing the > 5 
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cutoff score.  Additionally, past research made use of different instruments such as the BDI 
(Lesperance, & Frasure-Smith et al., 2000; Kaptein et al., 2005), Hospital Anxiety and 
Depression Scale (HADS) (Murphy et al., 2008), and the CES-D (Ariyo et al., 2000), among 
others, along with different cutoff scores, making comparisons to the results of this study 
somewhat problematic.  Finally, most studies included patients from only one diagnostic group 
making comparisons of the rates of depression between patients with differing diagnoses also 
very problematic.  
Therefore, it appears difficult to gain any meaningful comparisons from past research 
with this study.  Although this study seemed to show that amongst diagnostic groups, depression 
remains high if you start measuring beginning with mild depression and ending with severe 
depression     
Research Question Number Three 
 Research question three was designed to detect whether there were differences in the 
rates of depression between men and women who had been hospitalized with a cardiac diagnosis.  
This study found that about 72% of males were identified as depressed and 78% of females were 
identified as depressed.  Although more women were identified as being depressed at a higher 
rate than were men, the difference was not statistically significant in this study.  Faller et al. 
(2007) found no gender difference in rates of depression detected among heart failure patients.  
Alternatively, Naqvi et al. (2007) found that women did suffer higher rates of depression than did 
men after experiencing ACS.  
Danielsson and Johansen (2005) have suggested that men and women convey their 
experiences of depression differently, which may result in artificially higher rates of depression 
detected among women than among men.  This phenomenon is made manifest with men speaking 
more easily about physical distress than emotions, whereas women speak more readily about 
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emotional distress, shame and guilt.  Upon examination of the PHQ-9 it appears that of the nine 
questions asked, six questions have more of a physical component to them and only three 
questions have more of an emotional component to them.   
Therefore, it might appear that men would score higher as a whole on this questionnaire 
than would women.  This, however, did not hold true for this study.  Using surveys that are more 
specific to gender might yield better results.  
Research Question Number Four 
 Research question four was designed to determine whether there were differences in the 
rates of depression in patients who are married, single, widowed, or divorced.  In this study, no 
statistically significant differences were observed.   
 Prior research has come to the same conclusion. Chung et al. (2009) also found that 
levels of depressive symptoms were similar between married and nonmarried heart failure 
patients (10.9 vs. 12.1%).   Panagiotakos et al. (2008) found that hospitalized patients who were 
married or nonmarried had very similar rates of depression (20.4% and 22.8%). 
 Research seems to point in the same direction as the results of this study.  It may be that 
some people who are married have better social support than other married people and the same 
would be true in the nonmarried groups.  Similarly, social support may decrease depression in all 
of the marital status groups.  Social support, personality characteristics, and close relationships 
may have more to do with depression than marital status.  Marital status cannot be used as a 
proxy for social support.  Furthermore, we do not know what kind of depression a patient actually 
has.  It could be inherited, it could be chronic, or it could be acute. 
Research Question Number Five 
 Question five was designed to determine whether the age of the patient predicts the risk 
for depression.   This study found that age did not reliably predict depression in cardiac patients. 
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 Prior research seems to find the same kind of results.  The basic difference occurs when 
aging is associated with different types of disability, comorbidities and functional impairment.  
Healthy, normally functioning older adults are at no greater risk for depression than younger 
adults (Jorm, 2000; Roberts, Kaplan, Shema & Strawbridge, 1997).  This seems to be linked to 
the idea that an increase in comorbidities would also be linked to increased depression regardless 
of age. 
 Personality traits may play a big role in whether a person becomes depressed.  An 
optimistic older individual may fare much better than a pessimistic younger adult, regardless of 
comorbidities. 
 Bremmer et al. (2006) made a connection between older age predicting first cardiac 
events. Depressive disorders, and in particular, MDD in late life (75 years and greater) were 
mediated by subclinical atherosclerosis, which would confine the diagnoses to ischemic heart 
diseases. 
 Increased age, indeed, may have very little to do with depression.  The things that are 
more likely to predict depression could be things like marital status, education level, financial 
strain, chronic medical conditions, functional impairment, cognitive problems, life events, 
neighborhood problems, social isolation, and social support. 
Research Question Number Six 
 Question six was designed to detect whether there were differences between the rates of 
depression in patients that had a prior cardiac history versus those with a new diagnosis.  In this 
study, no difference was observed at a statistically significant level.   This researcher was unable 
to find any prior research that examined depression among these two groups. 
It may seem that a patient with a prior cardiac history has more reasons to be depressed, 
especially if long-term disability has been an issue.  On the other hand, if a patient has been 
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through a cardiac event before, he/she may feel more comfortable with the situation and have 
come to terms with the presence of heart disease in general.  They may feel that they have an 
“edge” on knowing how to recognize symptoms of a problem earlier, thus helping them to be able 
to take care of things in a more timely matter. They may have taken the time to educate 
themselves regarding their cardiac problems and made lifestyle modifications that make them feel 
more empowered and able to manage their disease effectively.  
It is very possible that personality characteristics could have something to do with how a 
patient may respond to a new diagnosis versus a prior history of cardiac problems.  A person that 
possesses the characteristics of optimism, may fair better than an individual that possessed the 
characteristic of pessimism in whatever group they might be a part of.  A hopeful patient may fair 
better than a hopeless patient.  
 For those individuals who come in with what would be classified as a new diagnosis, 
there are many arguments for and against depression.  A person who has never had any diagnosis 
of heart disease may not have any idea what is really happening to him/her and are not suspect of 
his/her heart in general.  If the diagnosis shows that the problem really does lie in their heart, they 
may find the situation depressing from the standpoint of not knowing what to expect in the future.  
Lack of understanding and education can be one of the biggest hurdles to conquer.  As these 
individuals gain more knowledge about their condition, the fear and depression will generally 
subside.  If the individual does not have the desire, time, or ability to gain more education about 
his/her condition, they may continue to have or it may result in higher levels of depression. 
 Ultimately, it would seem that prior versus new cardiac diagnosis has very little to do 
with depression.  Personality characteristics, past experience, environmental conditioning, 
socioeconomic level, comorbidities, and social support among others, would seem to have more 
influence on depression than prior versus new cardiac diagnosis. 
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Limitations of the Study 
 The results of this study revealed information that may be helpful to health education 
professionals in the future.  The study was designed to detect whether physicians are detecting 
depression in their patients that score > 5 on the PHQ-9 questionnaire. It was shown in this study 
that out of 83 patients that scored high enough to be categorized as depressed on the PHQ-9, only 
nine of those patients were identified by physicians. 
 Depression inventories are easy to administer and there are many in publication that are 
free to use and have good validity and reliability.  These inventories can be a simple, yet effective 
way of identifying cardiac patient’s who are depressed.  Many of these inventories are currently 
being used in many health care settings.  They are not only used, but are required by some 
governing bodies such as The American Association of Cardiovascular and Pulmonary Rehab 
(AACVPR) on a national level within all cardiac and pulmonary rehab programs.   
 In the hospital setting, a depression inventory could easily be given by a myriad of 
qualified practitioners, including health educators.  The physician need not be bothered except to 
be informed of the patients score and possibly the severity of depression based on results from the 
inventory.  The physician may then choose to address the situation while the patient is in the 
hospital or to simply follow up when the patient comes to the office for his/her follow-up 
appointment in approximately 2 to 4 weeks post discharge.  At the appointment, the inventory 
could be given to the patient to fill out with any required initial paperwork.  If depression persists, 
the physician could then begin to address the problem. 
 It appears that more emphasis needs to be given to depression detection in the cardiac 
patient from the moment of hospitalization and beyond. This is due to the fact that the longer 
depression persists, the higher the risk becomes for future cardiac events.  In the process of 
treating the whole patient, including any depressive symptoms, many of the somatic symptoms 
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might also be alleviated. 
 In our current society, health care reform and cost containment have become increasingly 
more important issues that are currently being addressed by the United States government.  It 
would seem that treating underlying psychosocial issues, such as depression, would not only be 
directly beneficial to the patient, but also would result in lower costs in the long term.  
Implications for Health Education 
 There were limitations to the present study that could be corrected by future researchers.  
The present study had a relatively small sample size that was not random in nature.  The sample 
was a convenience sample.  With a larger sample, more patients with the same diagnosis would 
be viewed and the percentages may be more even and not as high in some groups.   
 Unfortunately, the physician sample size was also very small.  There were only two 
cardiologists who practice at the facility where the study was being conducted.  Therefore, there 
was not a great deal of differing attitudes. Furthermore, both types of physicians, cardiologists 
and internal medicine, very infrequently even discuss depression in their notes.  Although there 
were quite a few more internal medicine physicians, the sample was still smaller than would be 
ideal.   
 Self-report surveys carry with them many limitations. The major limitation of the survey 
method is that it relies on a self-report method of data collection. Intentional deception, poor 
memory, or misunderstanding of the question can all contribute to inaccuracies in the data. 
Furthermore, this method is descriptive, not explanatory, and, therefore, cannot always offer any 
insights into cause-and-effect relationships. This may be corrected by the patient being 
interviewed by a professional in the field of psychology, and yet you would still have the problem 
of whether or not the patient would feel comfortable talking to a professional.  Beyond this, the 
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patient may have assumptions already formed that would cause them to not give truthful answers 
to the questions. 
A restriction of range is a definite possibility in this study, thereby limiting or reducing 
the size of the relationship between some factors and depression.  The sample was skewed when 
looking at age, marital status, and diagnostic group.  This may have reduced the size of the 
relationships found in this study.  Future research could stratify the sample by group status so that 
the numbers of participants in each group would be similar.  This might make the percentages of 
depression in each diagnostic group more representative. 
It is clear from prior work that depressed cardiac patients have poorer health-outcomes 
than do non-depressed patients.  Studies in the future could also attempt to break down the cost 
differences, if any, between the care provided for a depressed versus non-depressed cardiac 
patient.   
  Summary 
 This chapter has discussed the results of the analyses conducted on the data.  Implications 
for health educators, as well as recommendations for future research have been proposed.  This 
study found large differences between the rates of depression identified by the PHQ-9 (75%) and 
the rates of depression identified by physicians (10%).   
  With the addition of more diagnostic groups, the study was expanded.  In general, rates 
of depression in this study were higher in all groups than that found in prior research. Despite no 
statistical difference being achieved, this study suggests that depression rates may be higher than 
recently discovered.  Although more women were identified as being depressed at a higher rate 
than men, the difference was not statistically significant in this study. Age did not reliably predict 
depression in cardiac patients. 
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Patient Health Questionnaire – PHQ-9 
Name:_________________________ Date of Birth: ___ /___/___   
Age:_____ Todays Date:_____________  Gender:      Male        Female   
Race:    Caucasian     Hispanic     African American     Native American 
Do you have a past Cardiac History?         Yes       No    
Family Cardiac History?          Yes        No  
Marital Status:         Single         Married        Divorced        Widowed 
A.  Over the last 2 weeks, how often have you been bothered by any 
of the following problems?   (mark an X in the appropriate box) 
 Not 
at 
all 
Several 
days 
More 
than 
half 
the 
days 
Nearly 
every 
day 
1. Little interest or 
pleasure in doing things 
    
2. Feeling down, 
depressed or hopeless 
    
3. Trouble falling/staying 
asleep, sleeping too much 
    
4. Feeling tired or having 
little energy 
    
5. Poor appetite or 
overeating 
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Not 
at 
all 
Several 
days 
More 
than 
half 
the 
days 
Nearly 
every 
day 
6. Feeling bad about 
yourself – or that you are 
a failure or have let 
yourself or your family 
down 
    
7. Trouble concentrating 
on things, such as reading 
the newspaper or 
watching television 
    
8. Moving or speaking so 
slowly that other people 
could have noticed.  Or the 
opposite – being so fidgety 
or restless that you have 
been moving around a lot 
more than usual 
    
9. Thought that you would 
be better of dead or of 
hurting yourself in some 
way 
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B.  If you have been bothered by any of the 9 problems listed above, 
please answer the following: 
How difficult have these problems made it for you to do your 
work, take care of things at home, or get along with other 
people?  (mark an X under the correct level) 
Not difficult at 
all 
Somewhat 
difficult 
Very difficult Extremely 
difficult 
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INFORMED CONSENT                                                                            January 31,2009 
Detection of Depression in the Hospitalized Cardiac Patient 
Purpose of the Study:  Martine Geddes, a masters student in the Department of Health, Physical 
Education and Recreation at Utah State University, under the direction of Dr.Philip J.Waite, is 
conducting a research study to find out more about depression in the patient hospitalized for an 
acute coronary syndrome.  You have been asked to take part in an effort to better understand if 
depression is readily detected during a patients stay in the hospital.  The results of this study will 
impact future comprehensive care given to the cardiac patient. 
 
Procedures/Time to Participate:  If you agree to be in this research study, you will be asked to 
complete a brief questionnaire that should take approximately 5-10 minutes to complete.  When 
completed, you will give the questionnaire to your nurse, or Martine Geddes, who will then add 
your questionnaire to the research file. 
 
Risks:  There is minimal anticipated risks involved in participating in this study. 
 
Benefits:  There may or may not be any direct benefit to you for participating in this study.  
However, the knowledge gained from your participation may affect further treatment of 
depression in the hospitalized cardiac patient as we now know that depression is becoming an 
independent risk factor for heart disease. 
 
Explanation and Offer to Answer Questions:  You may ask questions concerning this research 
and have those questions answered before agreeing to participate.  If you have any questions 
about your rights as a participant in this study that have not been answered by the investigator, 
you may contact the Institutional Review Board at Utah State University (435) 797-1821 or Dr. 
Philip J. Waite at (435) 797-1000. 
 
Confidentiality:  The questionnaires completed for this study will identify you by name, only 
long enough to code your name and responses onto a specific code sheet.  This information will 
only be viewed by Dr. Phillip J. Waite and Martine Geddes.  Your Doctor will have no 
knowledge of your responses.  Research records will be kept confidential, consistent with federal 
and state regulations.  Records for this study will be kept in a locked cabinet in the university 
investigators office with no specific individual or department identified by name. 
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Freedom to Withdraw:  You are free to decide not to participate in this study or to withdraw at 
any time without adversely affecting your relationship with the investigators or with this 
institution. 
IRB Approval Statement:  The Institutional Review Board for the protection of human 
participants at Utah State University has approved this research study.  If you have any questions 
or concerns about your rights, you may contact the IRB Administrator at (435) 797-0567.  If you 
have a concern or complaint about the research and you would like to contact someone other than 
the research team, you may contact the IRB Administrator to obtain information or to offer input. 
 
Copy of Consent:  You have been given two copies of this Informed Consent.  Please sign both 
copies and retain one copy for your files. 
 
I certify that the research study has been explained to the individual by me, or by my research 
staff, and that the individual understands the nature and purpose, the possible risks and benefits 
associated with taking part in the research study.  Any questions that have been raised, have been 
answered. 
 
                                                                           /                                                       
Signature of Principal Investigator                                 Signature of Student Researcher or Co-PI 
Dr. Philip J. Waite                                                           Martine S. Geddes 
Principal Investigator (435) 797-1000                            Student Researcher  (435) 716-5323 
 
 
By signing below, I agree to participate 
 
 
______________________________________________     __________________________      
Participant signature                                                                    Date 
      
108 
 
 
 
 
 
 
 
 
 
 
APPENDIX C 
109 
Pilot Study Evaluation Form 
 
*place an X in the box that most closely corresponds to your answer 
 Strongly 
agree 
agree Not  
sure 
Disagree Strongly
disagree
1.  Were the survey questions easy 
to read and understand? 
     
2.  Was the format used to present 
the questions easy to follow? 
     
3.  Would you feel comfortable 
filling out this survey if you were a 
patient in the hospital? 
     
 
 
Comments:___________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
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Dear Physician, 
My name is Martine Geddes and I work for Logan Regional Hospital as the Clinical Lead 
in the Cardiac Rehabilitation program.  I am working on my master’s degree in Health 
Education at Utah State University.  As the final fulfillment of my degree, I am working 
on a thesis and would like to conduct a study in the Intensive Care Unit at Logan 
Regional Hospital.  My topic is “Detection of depression in the hospitalized cardiac 
patient”. 
I would like to get your permission to administer a simple, 9 question depression 
inventory to your patients that come into this unit with either a troponin blood test 
ordered, hx of CABG, AVR, MVR, or PTCA/Stent placement, ACS, R/O MI, atrial 
fibrillation, CHF, or unstable angina.  The depression inventory I’ve chosen to use is the 
Patient Health Questionnaire 9.  I have enclosed a copy for you to review.  In order to 
administer this questionnaire, patient informed consent will be obtained, and this is also 
enclosed for your review.  I expect the questionnaire to take approximately 5 minutes to 
complete and administration will not begin until the patient has reached a stable point in 
his/her hospitalization.  Patients excluded from the study would be those who are 
demented, on ventilatory support, on hospice, or expire during their hospitalization. 
Please review the physician consent form and sign and fax back to me if you are willing 
to allow me to administer this brief questionnaire to your patients (435) 716-2929.  You 
can also call me at (435) 716-5323. 
Your support would be greatly appreciated! 
 
Sincerely, 
 
Martine S. Geddes, B.S. 
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Physician Permission Form 
 
I agree to allow Martine Geddes, or a trained data collector 
working on her behalf, to administer the Patient Health 
Questionnaire (PHQ-9) to any of my patients that are admitted to 
the Intensive Care Unit at Logan Regional Hospital between 
October 2008 and November 2009 with either a troponin blood test 
ordered, hx of CABG, AVR, MVR, or a PTCA/Stent procedure, 
ACS, R/O MI, atrial fibrillation, CHF, or unstable angina. I 
understand that this questionnaire will not be administered until the 
patient is at a stable point in their hospitalization and informed 
consent has been obtained. 
 
 
 
________________________________________/_____________ 
Physician Signature                                                                  Date                     
    Fax to:  (435) 716-2929 
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